Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-let-7a-5p CSNK2A1 -0.03 0.25442 0.29 0.0016 miRNAWalker2 validate; TargetScan -0.7 0.00553
2 hsa-let-7b-5p CSNK2A1 -0.12 0.00077 0.29 0.0016 miRNAWalker2 validate -0.9 0
3 hsa-let-7b-5p EP300 -0.12 0.00077 0.11 0.05719 miRNAWalker2 validate -0.36 0.00159
4 hsa-let-7c-5p CSNK2A1 -0.13 0.00086 0.29 0.0016 miRNAWalker2 validate -0.81 0
5 hsa-let-7e-5p PPP2R1A -0.06 0.0129 0.19 0.00095 miRNAWalker2 validate -0.69 7.0E-5
6 hsa-miR-101-3p FZD6 -0.13 4.0E-5 0.2 0.17097 miRNAWalker2 validate; MirTarget -1.37 2.0E-5
7 hsa-miR-101-3p RAC1 -0.13 4.0E-5 0.12 0.00036 miRNAWalker2 validate; MirTarget -0.62 0
8 hsa-miR-106b-5p CCND1 0.17 0 -0.49 0.00116 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -1.84 0 23087084 Furthermore miR-106b upregulation in hepatoma cells modulated entry into the G1/S transitional phase by upregulating cyclin D1 and downregulating APC
9 hsa-miR-106b-5p CCND2 0.17 0 -0.02 0.79963 miRNAWalker2 validate; miRTarBase; miRNATAP -0.45 0.00359
10 hsa-miR-10a-5p BTRC -0.29 0 0.12 0.03999 miRNAWalker2 validate; miRTarBase; miRNATAP -0.21 0.00767
11 hsa-miR-10a-5p CSNK2A1 -0.29 0 0.29 0.0016 miRNAWalker2 validate -0.75 0
12 hsa-miR-10a-5p MAP3K7 -0.29 0 0.2 0.01129 miRNAWalker2 validate; miRTarBase; MirTarget -0.51 0
13 hsa-miR-10b-5p CSNK2A1 -0.03 0.44052 0.29 0.0016 miRNAWalker2 validate -0.45 0.01698
14 hsa-miR-122-5p RAC1 -0.14 0.00123 0.12 0.00036 miRNAWalker2 validate; miRTarBase -0.49 0
15 hsa-miR-122-5p RHOA -0.14 0.00123 0.09 4.0E-5 miRNAWalker2 validate; miRTarBase -0.28 0
16 hsa-miR-122-5p TBL1XR1 -0.14 0.00123 0.19 0.03766 miRNAWalker2 validate -0.48 0.00205
17 hsa-miR-125b-5p FRAT2 -0.19 1.0E-5 0.03 0.70845 miRNAWalker2 validate; miRNATAP -0.49 0.00035
18 hsa-miR-126-5p MMP7 0 0.93995 -1.4 3.0E-5 miRNAWalker2 validate -3.81 0.00035
19 hsa-miR-146a-5p ROCK1 -0.15 0.00019 -0.04 0.56308 miRNAWalker2 validate; miRTarBase -0.24 0.03156
20 hsa-miR-146a-5p SMAD4 -0.15 0.00019 -0.02 0.53799 miRNAWalker2 validate; miRTarBase -0.16 0.00261
21 hsa-miR-149-5p EP300 -0.01 0.59412 0.11 0.05719 miRNAWalker2 validate -0.33 0.03119
22 hsa-miR-155-5p SMAD4 0.04 0.14794 -0.02 0.53799 miRNAWalker2 validate -0.27 0.00018
23 hsa-miR-15b-5p CCND1 0.17 0 -0.49 0.00116 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -1.99 0
24 hsa-miR-16-5p TP53 0.05 0.02313 -0.01 0.88204 miRNAWalker2 validate; miRTarBase -0.65 0.02034
25 hsa-miR-17-5p CCND1 0.06 0.05778 -0.49 0.00116 miRNAWalker2 validate; MirTarget; TargetScan; miRNATAP -1.31 0.00018 18695042 Mammary epithelial cell-targeted cyclin D1 expression induced miR-17-5p and miR-20a expression in vivo and cyclin D1 bound the miR-17/20 cluster promoter regulatory region
26 hsa-miR-17-5p CCND2 0.06 0.05778 -0.02 0.79963 miRNAWalker2 validate; miRTarBase; TargetScan; miRNATAP -0.49 0.00112
27 hsa-miR-17-5p PRICKLE1 0.06 0.05778 -0.86 0 miRNAWalker2 validate -2.03 0
28 hsa-miR-17-5p SMAD3 0.06 0.05778 0.25 0.00236 miRNAWalker2 validate -0.46 0.01666
29 hsa-miR-181a-5p NLK -0.02 0.5042 0.18 0.00757 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.44 0.01709
30 hsa-miR-181a-5p WNT3A -0.02 0.5042 -0.04 0.27231 miRNAWalker2 validate -0.38 0.00037
31 hsa-miR-183-5p CCND1 0.21 6.0E-5 -0.49 0.00116 miRNAWalker2 validate -1.31 0
32 hsa-miR-183-5p PPP3R1 0.21 6.0E-5 0.02 0.75276 miRNAWalker2 validate -0.18 0.02923
33 hsa-miR-184 NFATC2 0.21 2.0E-5 -0.21 0.05152 miRNAWalker2 validate -0.62 4.0E-5
34 hsa-miR-18a-5p DAAM2 0.2 7.0E-5 -0.18 0.03531 miRNAWalker2 validate -0.79 0
35 hsa-miR-192-5p FZD1 0.01 0.72622 -0.71 0 miRNAWalker2 validate -1.67 0
36 hsa-miR-192-5p FZD7 0.01 0.72622 -0.29 0.05092 miRNAWalker2 validate -2.06 0
37 hsa-miR-192-5p PRICKLE1 0.01 0.72622 -0.86 0 miRNAWalker2 validate -1.61 1.0E-5
38 hsa-miR-192-5p TCF7 0.01 0.72622 0.15 0.21177 miRNAWalker2 validate; MirTarget -0.66 0.01943
39 hsa-miR-194-5p EP300 0.03 0.38268 0.11 0.05719 miRNAWalker2 validate -0.41 0.00207
40 hsa-miR-194-5p RAC1 0.03 0.38268 0.12 0.00036 miRNAWalker2 validate; miRTarBase; miRNATAP -0.34 2.0E-5
41 hsa-miR-196a-5p CCND2 0.07 0.01124 -0.02 0.79963 miRNAWalker2 validate -0.48 0.0035
42 hsa-miR-199a-3p MAPK9 -0.47 0 0.12 0.03801 miRNAWalker2 validate -0.19 0.0002
43 hsa-miR-19a-3p CCND1 0.02 0.47729 -0.49 0.00116 miRNAWalker2 validate; miRTarBase; miRNATAP -0.97 0.00857 25985117 Moreover miR-19a might play inhibitory roles in HCC malignancy via regulating Cyclin D1 expression
44 hsa-miR-19b-3p CCND2 -0.02 0.40277 -0.02 0.79963 miRNAWalker2 validate; MirTarget; miRNATAP -0.39 0.02187
45 hsa-miR-19b-3p DAAM2 -0.02 0.40277 -0.18 0.03531 miRNAWalker2 validate -0.46 0.03964
46 hsa-miR-19b-3p PRKACB -0.02 0.40277 -0.14 0.14062 miRNAWalker2 validate; MirTarget; miRNATAP -0.68 0.00546
47 hsa-miR-200a-3p TCF7L1 -0.48 0 0.03 0.57819 miRNAWalker2 validate -0.1 0.04142
48 hsa-miR-200b-3p TCF7L1 -0.53 0 0.03 0.57819 miRNAWalker2 validate -0.1 0.04374
49 hsa-miR-206 CCND2 0.03 0.13251 -0.02 0.79963 miRNAWalker2 validate; PITA; miRNATAP -0.49 0.02842 23348698 Further studies demonstrated that miR-206 could suppress GC cells proliferation at least partially through targeting the cyclinD2 CCND2
50 hsa-miR-20a-5p CCND1 -0.02 0.56346 -0.49 0.00116 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.89 0.00952
51 hsa-miR-20a-5p CCND2 -0.02 0.56346 -0.02 0.79963 miRNAWalker2 validate; miRTarBase; miRNATAP -0.44 0.00293
52 hsa-miR-21-5p DAAM1 0.23 0.00018 -0.1 0.25736 miRNAWalker2 validate -0.41 2.0E-5
53 hsa-miR-21-5p PRICKLE2 0.23 0.00018 -0.71 2.0E-5 miRNAWalker2 validate; MirTarget -0.8 3.0E-5
54 hsa-miR-210-3p APC 0.07 0.15598 0.05 0.42978 miRNAWalker2 validate -0.18 0.03052
55 hsa-miR-214-3p CTNNB1 -0.32 0 0.21 0.02055 miRNAWalker2 validate; miRTarBase; MirTarget -0.29 0.02012 22962603; 22962603 The enhancer of zeste homologue 2 EZH2 and β-catenin CTNNB1 was identified as two potential direct downstream targets of miR-214 through bioinformatics analysis and experimentally validated the miRNA-target interactions with a dual-firefly luciferase reporter assay;Furthermore the silencing of miR-214 or overexpression of EZH2 increased EpCAM+ stem-like cells through the activation of CTNNB1
56 hsa-miR-215-5p FZD1 0.04 0.21421 -0.71 0 miRNAWalker2 validate -1.72 0
57 hsa-miR-215-5p FZD7 0.04 0.21421 -0.29 0.05092 miRNAWalker2 validate -2.02 0
58 hsa-miR-215-5p PRICKLE1 0.04 0.21421 -0.86 0 miRNAWalker2 validate -1.61 1.0E-5
59 hsa-miR-215-5p TCF7 0.04 0.21421 0.15 0.21177 miRNAWalker2 validate; MirTarget -0.62 0.02313
60 hsa-miR-22-3p CSNK2A1 -0.08 0.02671 0.29 0.0016 miRNAWalker2 validate -1.01 0
61 hsa-miR-22-3p FRAT2 -0.08 0.02671 0.03 0.70845 miRNAWalker2 validate; MirTarget; miRNATAP -0.73 2.0E-5
62 hsa-miR-221-3p LRP6 0.19 0 -0.15 0.01529 miRNAWalker2 validate -0.51 0
63 hsa-miR-23b-3p EP300 0.01 0.57764 0.11 0.05719 miRNAWalker2 validate -0.48 0.04041
64 hsa-miR-24-3p FZD5 -0.01 0.59303 0.16 0.05185 miRNAWalker2 validate; miRNATAP -1.08 0.00069
65 hsa-miR-26a-5p CTBP1 -0.08 7.0E-5 0.12 0.00038 miRNAWalker2 validate -0.41 0.0007
66 hsa-miR-26a-5p GSK3B -0.08 7.0E-5 0.1 0.09041 miRNAWalker2 validate; miRNATAP -0.51 0.02109
67 hsa-miR-26b-5p EP300 -0.05 0.04928 0.11 0.05719 miRNAWalker2 validate; miRNATAP -0.52 0.00197
68 hsa-miR-26b-5p RUVBL1 -0.05 0.04928 0.32 1.0E-5 miRNAWalker2 validate -1.1 0
69 hsa-miR-26b-5p SFRP4 -0.05 0.04928 0.72 0.01772 miRNAWalker2 validate -5.01 0
70 hsa-miR-26b-5p VANGL1 -0.05 0.04928 0.11 0.21591 miRNAWalker2 validate; mirMAP -0.64 0.02298
71 hsa-miR-26b-5p VANGL2 -0.05 0.04928 -0.36 0.11321 miRNAWalker2 validate; MirTarget -2.8 3.0E-5
72 hsa-miR-27b-3p CCND3 -0 0.86264 -0.19 0.01071 miRNAWalker2 validate -0.68 0.01531
73 hsa-miR-29a-3p DKK1 -0.02 0.42365 1.1 0.00028 miRNAWalker2 validate; miRTarBase -2.19 0.00661
74 hsa-miR-301a-3p CCND2 0.32 0 -0.02 0.79963 miRNAWalker2 validate -0.21 0.0097
75 hsa-miR-302a-3p CCND1 0.02 0.58031 -0.49 0.00116 miRNAWalker2 validate; miRTarBase; TargetScan; miRNATAP -1.39 0.0002
76 hsa-miR-302c-3p CCND1 0.05 0.06697 -0.49 0.00116 miRNAWalker2 validate; miRTarBase -1.51 0.00013
77 hsa-miR-30a-3p EP300 0.03 0.21224 0.11 0.05719 miRNAWalker2 validate; MirTarget; miRNATAP -0.62 0.00011
78 hsa-miR-30c-5p CSNK1E -0.05 0.0598 0.28 0.00101 miRNAWalker2 validate -1.74 0
79 hsa-miR-30c-5p EP300 -0.05 0.0598 0.11 0.05719 miRNAWalker2 validate -0.71 1.0E-5
80 hsa-miR-30c-5p PLCB1 -0.05 0.0598 0.8 0 miRNAWalker2 validate -3.75 0
81 hsa-miR-30c-5p RAC1 -0.05 0.0598 0.12 0.00036 miRNAWalker2 validate -0.65 0
82 hsa-miR-30c-5p TBL1XR1 -0.05 0.0598 0.19 0.03766 miRNAWalker2 validate -0.59 0.02717
83 hsa-miR-320a FRAT2 0.02 0.22623 0.03 0.70845 miRNAWalker2 validate -0.77 0.01126
84 hsa-miR-324-3p CSNK1A1 0.02 0.24561 -0.14 0.02274 miRNAWalker2 validate -0.48 0.04209
85 hsa-miR-324-3p WNT9B 0.02 0.24561 -0.32 0.01981 miRNAWalker2 validate -1.33 0.01182
86 hsa-miR-335-5p FZD10 0.02 0.79934 0.21 0.03364 miRNAWalker2 validate -0.19 0.04285
87 hsa-miR-335-5p FZD8 0.02 0.79934 -0.26 0.04869 miRNAWalker2 validate -0.34 0.00766
88 hsa-miR-335-5p PRICKLE2 0.02 0.79934 -0.71 2.0E-5 miRNAWalker2 validate -0.33 0.04103
89 hsa-miR-335-5p VANGL2 0.02 0.79934 -0.36 0.11321 miRNAWalker2 validate -0.54 0.0106
90 hsa-miR-33a-5p MAPK8 0.16 0 -0.17 0.0118 miRNAWalker2 validate -0.91 0
91 hsa-miR-34b-5p MYC 0.11 0.00023 -0.48 0.01676 miRNAWalker2 validate; miRTarBase -2.38 0
92 hsa-miR-34c-5p MYC 0.2 5.0E-5 -0.48 0.01676 miRNAWalker2 validate; miRTarBase; miRanda -0.66 0.02032 22370637 We demonstrate that Bmf Bcl-2-modifying factor is a target of miR-34c-5p and that its silencing together with that of c-myc a known target of miR-34c-5p contributes to resistance to apoptosis induced by paclitaxel through p53 downregulation
93 hsa-miR-375 PRKCA -0.55 0 0.19 0.01548 miRNAWalker2 validate -0.18 0.00108 23497265 The integrated analysis of miRNA and mRNA expression identified 35 known and novel target genes of miR-200c miR-205 and mir-375 including CFL2 LAMC1 TIMP2 ZEB1 CDH11 PRKCA PTPRJ PTPRM LDHB and SEC23A
94 hsa-miR-375 RHOA -0.55 0 0.09 4.0E-5 miRNAWalker2 validate -0.08 0
95 hsa-miR-429 TCF7L1 -0.08 0.00239 0.03 0.57819 miRNAWalker2 validate -0.55 0.00092
96 hsa-miR-7-5p CAMK2D 0.11 7.0E-5 -0.2 0.00605 miRNAWalker2 validate -0.52 0.0053
97 hsa-miR-7-5p LRP6 0.11 7.0E-5 -0.15 0.01529 miRNAWalker2 validate; miRNATAP -0.61 7.0E-5
98 hsa-miR-9-5p CCND1 0.21 0.00475 -0.49 0.00116 miRNAWalker2 validate -0.51 0.00055
99 hsa-miR-9-5p NFATC3 0.21 0.00475 -0.2 0.00031 miRNAWalker2 validate; MirTarget; miRNATAP -0.16 0.00247
100 hsa-miR-92a-3p GSK3B -0.03 0.37888 0.1 0.09041 miRNAWalker2 validate -0.51 0.00114
101 hsa-miR-92a-3p PPARD -0.03 0.37888 0.12 0.01438 miRNAWalker2 validate -0.27 0.02806
102 hsa-miR-92a-3p PRKCA -0.03 0.37888 0.19 0.01548 miRNAWalker2 validate -0.55 0.00495
103 hsa-miR-93-5p CCND1 0.19 0 -0.49 0.00116 miRNAWalker2 validate; MirTarget; miRNATAP -1.94 0 25371073 Furthermore miR-93 may downregulate the Wnt/β-catenin pathway which was confirmed by measuring the expression level of the β-catenin axin c-Myc and cyclin-D1 in this pathway
104 hsa-miR-93-5p JUN 0.19 0 -0.5 5.0E-5 miRNAWalker2 validate -1.06 0.00026
105 hsa-miR-135b-5p APC -0.11 0.00127 0.05 0.42978 miRTarBase; MirTarget -0.28 0.02881
106 hsa-miR-100-5p FZD5 -0.14 0.00081 0.16 0.05185 MirTarget; miRNATAP -0.47 0.00056
107 hsa-miR-101-3p NLK -0.13 4.0E-5 0.18 0.00757 MirTarget; miRNATAP -0.34 0.02683
108 hsa-miR-103a-3p WNT7A 0.11 0 -0.11 0.01687 MirTarget -0.3 0.02794
109 hsa-miR-105-5p PRICKLE2 0.17 0.00159 -0.71 2.0E-5 MirTarget; miRNATAP -0.76 0.00048
110 hsa-miR-105-5p PRKX 0.17 0.00159 0.03 0.73526 MirTarget -0.31 0.00608
111 hsa-miR-106a-5p CCND1 0.05 0.12421 -0.49 0.00116 MirTarget; miRNATAP -1.17 0.00029
112 hsa-miR-10a-5p CAMK2G -0.29 0 0.2 0.00105 MirTarget; miRNATAP -0.56 0
113 hsa-miR-10b-5p CAMK2G -0.03 0.44052 0.2 0.00105 MirTarget; miRNATAP -0.34 0.00684
114 hsa-miR-124-3p NFATC2 0.08 0.04068 -0.21 0.05152 MirTarget; miRNATAP -0.51 0.01381
115 hsa-miR-125a-5p CSNK2A1 -0.13 0.00014 0.29 0.0016 MirTarget; PITA; miRanda -0.64 0.00109
116 hsa-miR-125b-5p CSNK2A1 -0.19 1.0E-5 0.29 0.0016 MirTarget; miRNATAP -0.86 0
117 hsa-miR-126-5p PRKX 0 0.93995 0.03 0.73526 MirTarget; miRNATAP -0.9 0.00101
118 hsa-miR-126-5p MAP3K7 0 0.93995 0.2 0.01129 MirTarget -0.94 0.00011
119 hsa-miR-128-3p PPP2R1B 0.08 0.0018 -0.02 0.78139 MirTarget -0.45 0.01384
120 hsa-miR-128-3p VANGL2 0.08 0.0018 -0.36 0.11321 MirTarget -2.59 3.0E-5
121 hsa-miR-128-3p PRKX 0.08 0.0018 0.03 0.73526 MirTarget -0.54 0.02703
122 hsa-miR-129-5p EP300 -0.01 0.79472 0.11 0.05719 MirTarget; PITA; miRanda; miRNATAP -0.29 0.02668
123 hsa-miR-130a-3p TBL1XR1 -0.19 0 0.19 0.03766 MirTarget -0.44 0.00429
124 hsa-miR-130b-3p FOSL1 0.19 4.0E-5 -0.54 0.00109 MirTarget -1.34 0
125 hsa-miR-130b-3p DAAM1 0.19 4.0E-5 -0.1 0.25736 MirTarget; miRNATAP -0.54 3.0E-5
126 hsa-miR-136-5p FZD4 -0.05 0.32506 0.05 0.55827 MirTarget -0.3 0.00572
127 hsa-miR-137 MAP3K7 0.03 0.28838 0.2 0.01129 MirTarget; miRanda -0.5 0.00936
128 hsa-miR-138-5p DVL2 -0.21 0.00013 0.39 0 MirTarget; miRNATAP -0.27 0.00652
129 hsa-miR-138-5p CAMK2A -0.21 0.00013 0.15 0.05444 MirTarget -0.27 0.00921
130 hsa-miR-139-5p PRKX -0.08 0.00239 0.03 0.73526 MirTarget -0.98 9.0E-5
131 hsa-miR-139-5p MAP3K7 -0.08 0.00239 0.2 0.01129 MirTarget -1.25 0
132 hsa-miR-139-5p PPP3CB -0.08 0.00239 0.2 0.00445 MirTarget; PITA; miRanda -0.65 0.00185
133 hsa-miR-142-3p TBL1X -0.06 0.14584 0.31 0.00218 MirTarget; PITA; miRanda; miRNATAP -0.54 0.00184
134 hsa-miR-143-3p CSNK2A1 -0.09 0.00824 0.29 0.0016 MirTarget -0.74 7.0E-5
135 hsa-miR-143-3p MAP3K7 -0.09 0.00824 0.2 0.01129 MirTarget; miRNATAP -0.48 0.0026
136 hsa-miR-144-3p TBL1XR1 -0.11 0.02244 0.19 0.03766 MirTarget -0.35 0.00894
137 hsa-miR-144-3p PRKX -0.11 0.02244 0.03 0.73526 MirTarget -0.29 0.02356
138 hsa-miR-145-5p SENP2 -0.2 0 0.15 0.009 MirTarget -0.42 3.0E-5
139 hsa-miR-145-5p SMAD2 -0.2 0 0.23 0.00027 MirTarget -0.39 0.00037
140 hsa-miR-146a-5p RAC1 -0.15 0.00019 0.12 0.00036 MirTarget -0.19 0.00158
141 hsa-miR-147a CCND1 0.09 0.00179 -0.49 0.00116 MirTarget -2.3 0
142 hsa-miR-147a NFAT5 0.09 0.00179 -0.12 0.30997 MirTarget; miRNATAP -0.61 0.0278
143 hsa-miR-148a-3p SMAD2 -0.01 0.73806 0.23 0.00027 MirTarget; mirMAP -0.6 0
144 hsa-miR-148a-3p PRKX -0.01 0.73806 0.03 0.73526 MirTarget -0.79 0
145 hsa-miR-148b-3p PRICKLE2 0.14 0 -0.71 2.0E-5 MirTarget; miRNATAP -2.73 0
146 hsa-miR-150-5p DVL3 -0.18 0.00075 0.11 0.00083 MirTarget -0.28 0
147 hsa-miR-150-5p NLK -0.18 0.00075 0.18 0.00757 MirTarget -0.44 0
148 hsa-miR-152-3p PRICKLE2 -0 0.97674 -0.71 2.0E-5 MirTarget -0.99 0.0065
149 hsa-miR-152-3p SMAD2 -0 0.97674 0.23 0.00027 MirTarget -0.63 0
150 hsa-miR-152-3p PRKX -0 0.97674 0.03 0.73526 MirTarget -0.62 0.00095
NumGOOverlapSizeP ValueAdj. P Value
1 WNT SIGNALING PATHWAY 77 351 1.039e-106 4.836e-103
2 CANONICAL WNT SIGNALING PATHWAY 40 95 1.058e-65 2.462e-62
3 NON CANONICAL WNT SIGNALING PATHWAY 37 140 1.188e-51 1.842e-48
4 REGULATION OF WNT SIGNALING PATHWAY 45 310 1.781e-50 2.071e-47
5 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 33 236 4.847e-36 4.511e-33
6 POSITIVE REGULATION OF RESPONSE TO STIMULUS 66 1929 1.915e-35 1.273e-32
7 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 31 197 1.693e-35 1.273e-32
8 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 50 1021 7.638e-33 4.442e-30
9 POSITIVE REGULATION OF CELL COMMUNICATION 58 1532 1.049e-32 5.423e-30
10 REGULATION OF ORGAN MORPHOGENESIS 30 242 4.2e-31 1.954e-28
11 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 58 1672 1.146e-30 4.848e-28
12 WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY 18 39 1.768e-30 6.855e-28
13 REGULATION OF PROTEIN MODIFICATION PROCESS 58 1710 3.796e-30 1.359e-27
14 TISSUE MORPHOGENESIS 37 533 3.667e-29 1.219e-26
15 POSITIVE REGULATION OF GENE EXPRESSION 57 1733 7.631e-29 2.367e-26
16 EPITHELIUM DEVELOPMENT 45 945 9.362e-29 2.723e-26
17 REGULATION OF PHOSPHORUS METABOLIC PROCESS 55 1618 2.176e-28 5.956e-26
18 MORPHOGENESIS OF AN EPITHELIUM 33 400 2.335e-28 6.036e-26
19 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 53 1492 3.905e-28 9.564e-26
20 TISSUE DEVELOPMENT 53 1518 9.03e-28 2.101e-25
21 ORGAN MORPHOGENESIS 42 841 1.598e-27 3.542e-25
22 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 24 162 7.632e-27 1.614e-24
23 BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY 14 22 1.243e-26 2.515e-24
24 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY 21 110 5.135e-26 9.956e-24
25 TUBE MORPHOGENESIS 29 323 5.977e-26 1.112e-23
26 TUBE DEVELOPMENT 33 552 7.265e-24 1.3e-21
27 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 43 1135 1.997e-23 3.441e-21
28 REGULATION OF CELL DIFFERENTIATION 48 1492 2.603e-23 4.325e-21
29 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 52 1805 2.851e-23 4.575e-21
30 EMBRYONIC MORPHOGENESIS 32 539 4.861e-23 7.539e-21
31 NEURON DIFFERENTIATION 38 874 1.23e-22 1.845e-20
32 EMBRYO DEVELOPMENT 38 894 2.72e-22 3.954e-20
33 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 40 1036 5.438e-22 7.442e-20
34 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 40 1036 5.438e-22 7.442e-20
35 NEUROGENESIS 45 1402 1.123e-21 1.493e-19
36 POSITIVE REGULATION OF MOLECULAR FUNCTION 50 1791 1.166e-21 1.507e-19
37 NEGATIVE REGULATION OF CELL COMMUNICATION 42 1192 1.208e-21 1.519e-19
38 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 31 554 1.484e-21 1.817e-19
39 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 44 1360 2.737e-21 3.266e-19
40 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 41 1152 2.945e-21 3.426e-19
41 REGULATION OF EMBRYONIC DEVELOPMENT 18 114 7.862e-21 8.922e-19
42 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 26 365 1.027e-20 1.138e-18
43 REGULATION OF CELLULAR PROTEIN LOCALIZATION 30 552 1.691e-20 1.83e-18
44 REGULATION OF CELL CYCLE 37 949 2.063e-20 2.182e-18
45 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 37 957 2.736e-20 2.829e-18
46 CARDIOVASCULAR SYSTEM DEVELOPMENT 34 788 4.431e-20 4.386e-18
47 CIRCULATORY SYSTEM DEVELOPMENT 34 788 4.431e-20 4.386e-18
48 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 19 152 6.14e-20 5.952e-18
49 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 48 1848 2.185e-19 2.075e-17
50 PATTERN SPECIFICATION PROCESS 26 418 3.066e-19 2.854e-17
51 CELL FATE COMMITMENT 21 227 3.505e-19 3.198e-17
52 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 45 1656 8.127e-19 7.135e-17
53 REGULATION OF CELL PROLIFERATION 43 1496 8.033e-19 7.135e-17
54 REGIONALIZATION 23 311 9.587e-19 8.261e-17
55 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 38 1142 1.24e-18 1.049e-16
56 SENSORY ORGAN DEVELOPMENT 27 493 1.503e-18 1.249e-16
57 POSITIVE REGULATION OF CELL DIFFERENTIATION 33 823 1.611e-18 1.315e-16
58 REGULATION OF BINDING 22 283 2.014e-18 1.615e-16
59 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 46 1784 2.268e-18 1.789e-16
60 REGULATION OF CELL DEATH 42 1472 3.092e-18 2.398e-16
61 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 17 134 4.782e-18 3.648e-16
62 DORSAL VENTRAL AXIS SPECIFICATION 10 20 7.893e-18 5.923e-16
63 REGULATION OF PROTEIN LOCALIZATION 34 950 1.417e-17 1.046e-15
64 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 40 1395 2.168e-17 1.576e-15
65 CELL PROLIFERATION 29 672 4.069e-17 2.913e-15
66 REGULATION OF CELLULAR RESPONSE TO STRESS 29 691 8.514e-17 6.003e-15
67 CELLULAR RESPONSE TO RETINOIC ACID 13 65 9.465e-17 6.573e-15
68 INTRACELLULAR SIGNAL TRANSDUCTION 41 1572 2.122e-16 1.452e-14
69 POSITIVE REGULATION OF CELL DEATH 27 605 2.573e-16 1.735e-14
70 EMBRYONIC ORGAN DEVELOPMENT 23 406 3.417e-16 2.271e-14
71 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 30 801 4.978e-16 3.262e-14
72 POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 15 119 5.335e-16 3.448e-14
73 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 33 1004 5.715e-16 3.642e-14
74 HEART DEVELOPMENT 24 466 6.141e-16 3.861e-14
75 PROTEIN PHOSPHORYLATION 32 944 7.334e-16 4.55e-14
76 REGULATION OF RESPONSE TO STRESS 39 1468 7.985e-16 4.889e-14
77 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 21 337 1.136e-15 6.867e-14
78 REGULATION OF HYDROLASE ACTIVITY 37 1327 1.206e-15 7.192e-14
79 TUBE FORMATION 15 129 1.834e-15 1.08e-13
80 CELL DEVELOPMENT 38 1426 1.914e-15 1.113e-13
81 REGULATION OF JNK CASCADE 16 159 2.063e-15 1.185e-13
82 REGULATION OF CELLULAR LOCALIZATION 36 1277 2.335e-15 1.325e-13
83 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 39 1517 2.366e-15 1.327e-13
84 POSITIVE REGULATION OF CATALYTIC ACTIVITY 39 1518 2.418e-15 1.34e-13
85 ANTERIOR POSTERIOR PATTERN SPECIFICATION 17 194 2.686e-15 1.47e-13
86 RESPONSE TO RETINOIC ACID 14 107 3.087e-15 1.67e-13
87 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 17 197 3.474e-15 1.858e-13
88 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 24 513 5.212e-15 2.756e-13
89 SENSORY ORGAN MORPHOGENESIS 18 239 5.564e-15 2.909e-13
90 REGULATION OF TRANSFERASE ACTIVITY 31 946 5.776e-15 2.986e-13
91 EMBRYONIC ORGAN MORPHOGENESIS 19 279 5.849e-15 2.991e-13
92 SEGMENTATION 13 89 7.182e-15 3.632e-13
93 AXIS SPECIFICATION 13 90 8.352e-15 4.147e-13
94 NEGATIVE REGULATION OF GENE EXPRESSION 38 1493 8.377e-15 4.147e-13
95 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 21 381 1.302e-14 6.376e-13
96 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 17 220 2.186e-14 1.06e-12
97 GASTRULATION 15 155 2.929e-14 1.405e-12
98 EPITHELIAL TO MESENCHYMAL TRANSITION 11 56 2.959e-14 1.405e-12
99 REGULATION OF CELL CYCLE PROCESS 24 558 3.308e-14 1.548e-12
100 REGULATION OF PROTEIN TARGETING 19 307 3.326e-14 1.548e-12
101 SOMITE DEVELOPMENT 12 78 4.274e-14 1.969e-12
102 CELLULAR RESPONSE TO LIPID 22 457 4.568e-14 2.064e-12
103 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 21 406 4.537e-14 2.064e-12
104 DOPAMINERGIC NEURON DIFFERENTIATION 9 28 5.033e-14 2.252e-12
105 REGULATION OF ORGANELLE ORGANIZATION 33 1178 5.523e-14 2.447e-12
106 RESPONSE TO LIPID 29 888 5.657e-14 2.461e-12
107 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 15 162 5.66e-14 2.461e-12
108 BETA CATENIN TCF COMPLEX ASSEMBLY 10 43 7.291e-14 3.141e-12
109 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 14 135 8.408e-14 3.589e-12
110 NEGATIVE REGULATION OF CELL PROLIFERATION 25 643 8.768e-14 3.709e-12
111 REGULATION OF CELL DEVELOPMENT 28 836 9.003e-14 3.774e-12
112 SOMITOGENESIS 11 62 9.799e-14 4.071e-12
113 RESPONSE TO GROWTH FACTOR 22 475 9.991e-14 4.114e-12
114 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 42 1977 1.035e-13 4.225e-12
115 REGULATION OF KINASE ACTIVITY 27 776 1.094e-13 4.425e-12
116 REGULATION OF CYTOPLASMIC TRANSPORT 22 481 1.287e-13 5.164e-12
117 RESPONSE TO OXYGEN CONTAINING COMPOUND 35 1381 1.493e-13 5.936e-12
118 FC EPSILON RECEPTOR SIGNALING PATHWAY 14 142 1.707e-13 6.731e-12
119 REGULATION OF CELL MORPHOGENESIS 23 552 2.355e-13 9.207e-12
120 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 26 740 2.697e-13 1.046e-11
121 DORSAL VENTRAL PATTERN FORMATION 12 91 2.907e-13 1.118e-11
122 NEURAL TUBE DEVELOPMENT 14 149 3.338e-13 1.271e-11
123 REGULATION OF INTRACELLULAR TRANSPORT 24 621 3.359e-13 1.271e-11
124 REGULATION OF PROTEIN IMPORT 15 183 3.431e-13 1.287e-11
125 NEURAL TUBE FORMATION 12 94 4.334e-13 1.613e-11
126 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 23 573 5.111e-13 1.887e-11
127 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 16 228 5.955e-13 2.148e-11
128 MESENCHYME DEVELOPMENT 15 190 5.949e-13 2.148e-11
129 STEM CELL DIFFERENTIATION 15 190 5.949e-13 2.148e-11
130 REGULATION OF CELLULAR COMPONENT BIOGENESIS 26 767 6.123e-13 2.192e-11
131 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE 7 14 8.248e-13 2.929e-11
132 PHOSPHORYLATION 32 1228 1.034e-12 3.643e-11
133 REGULATION OF MAPK CASCADE 24 660 1.235e-12 4.32e-11
134 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 26 799 1.55e-12 5.381e-11
135 POSITIVE REGULATION OF CELL CYCLE 18 332 1.572e-12 5.419e-11
136 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 27 876 1.9e-12 6.501e-11
137 REGULATION OF JUN KINASE ACTIVITY 11 81 2.123e-12 7.211e-11
138 PROTEIN COMPLEX SUBUNIT ORGANIZATION 35 1527 2.727e-12 9.193e-11
139 CELLULAR RESPONSE TO ACID CHEMICAL 14 175 3.065e-12 1.019e-10
140 RHYTHMIC PROCESS 17 298 3.058e-12 1.019e-10
141 REGULATION OF TRANSPORT 38 1804 3.091e-12 1.02e-10
142 CELL ACTIVATION 22 568 3.532e-12 1.157e-10
143 PALATE DEVELOPMENT 11 85 3.661e-12 1.191e-10
144 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 13 144 4.073e-12 1.316e-10
145 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 15 218 4.38e-12 1.4e-10
146 POSITIVE REGULATION OF JUN KINASE ACTIVITY 10 63 4.392e-12 1.4e-10
147 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 28 983 4.522e-12 1.431e-10
148 REPRODUCTIVE SYSTEM DEVELOPMENT 19 408 5.19e-12 1.632e-10
149 MACROMOLECULAR COMPLEX DISASSEMBLY 14 182 5.233e-12 1.634e-10
150 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 18 360 6.102e-12 1.893e-10
151 CELL CYCLE 32 1316 6.502e-12 2.004e-10
152 CELL DEATH 28 1001 6.956e-12 2.111e-10
153 MIDBRAIN DEVELOPMENT 11 90 6.961e-12 2.111e-10
154 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 20 470 6.988e-12 2.111e-10
155 NEGATIVE REGULATION OF MOLECULAR FUNCTION 29 1079 7.182e-12 2.156e-10
156 CELL CYCLE PROCESS 29 1081 7.513e-12 2.241e-10
157 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 17 323 1.102e-11 3.266e-10
158 NEGATIVE REGULATION OF CELL DIFFERENTIATION 22 609 1.379e-11 4.062e-10
159 MUSCLE STRUCTURE DEVELOPMENT 19 432 1.399e-11 4.094e-10
160 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 22 616 1.722e-11 5.007e-10
161 MORPHOGENESIS OF A BRANCHING STRUCTURE 13 167 2.694e-11 7.785e-10
162 FC RECEPTOR SIGNALING PATHWAY 14 206 2.792e-11 8.02e-10
163 REGULATION OF PROTEIN BINDING 13 168 2.905e-11 8.293e-10
164 MESENCHYMAL CELL DIFFERENTIATION 12 134 3.124e-11 8.863e-10
165 REGULATION OF CELLULAR COMPONENT MOVEMENT 24 771 3.214e-11 9.063e-10
166 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 20 514 3.494e-11 9.793e-10
167 HEAD DEVELOPMENT 23 709 3.876e-11 1.08e-09
168 HEART MORPHOGENESIS 14 212 4.103e-11 1.136e-09
169 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 15 258 4.848e-11 1.335e-09
170 REGULATION OF MITOTIC CELL CYCLE 19 468 5.531e-11 1.514e-09
171 POSITIVE REGULATION OF MAPK CASCADE 19 470 5.948e-11 1.619e-09
172 POSITIVE REGULATION OF CELL DEVELOPMENT 19 472 6.395e-11 1.73e-09
173 EMBRYONIC PATTERN SPECIFICATION 9 58 6.668e-11 1.786e-09
174 KIDNEY MORPHOGENESIS 10 82 6.678e-11 1.786e-09
175 NEGATIVE REGULATION OF CELL DEATH 25 872 6.766e-11 1.799e-09
176 REGULATION OF PROTEIN PHOSPHATASE TYPE 2A ACTIVITY 7 24 7.912e-11 2.092e-09
177 REGULATION OF STEM CELL DIFFERENTIATION 11 113 8.659e-11 2.276e-09
178 POSITIVE REGULATION OF KINASE ACTIVITY 19 482 9.135e-11 2.382e-09
179 REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 9 60 9.163e-11 2.382e-09
180 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 17 370 9.28e-11 2.399e-09
181 RESPONSE TO ACID CHEMICAL 16 319 9.529e-11 2.45e-09
182 PROTEASOMAL PROTEIN CATABOLIC PROCESS 15 271 9.69e-11 2.477e-09
183 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 23 750 1.181e-10 3.003e-09
184 CONVERGENT EXTENSION 6 14 1.249e-10 3.142e-09
185 CELLULAR RESPONSE TO STRESS 33 1565 1.249e-10 3.142e-09
186 CELLULAR COMPONENT MORPHOGENESIS 25 900 1.318e-10 3.279e-09
187 EYE DEVELOPMENT 16 326 1.313e-10 3.279e-09
188 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 15 282 1.692e-10 4.187e-09
189 MESONEPHROS DEVELOPMENT 10 90 1.715e-10 4.222e-09
190 MITOTIC CELL CYCLE 23 766 1.789e-10 4.374e-09
191 DEVELOPMENTAL GROWTH 16 333 1.796e-10 4.374e-09
192 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 11 121 1.826e-10 4.425e-09
193 REGULATION OF CATENIN IMPORT INTO NUCLEUS 7 27 2e-10 4.821e-09
194 MESODERM MORPHOGENESIS 9 66 2.226e-10 5.338e-09
195 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 15 289 2.382e-10 5.683e-09
196 GLAND DEVELOPMENT 17 395 2.55e-10 6.054e-09
197 KIDNEY EPITHELIUM DEVELOPMENT 11 125 2.599e-10 6.138e-09
198 SINGLE ORGANISM CELL ADHESION 18 459 3.254e-10 7.648e-09
199 PARAXIAL MESODERM DEVELOPMENT 6 16 3.298e-10 7.711e-09
200 RESPONSE TO ENDOGENOUS STIMULUS 31 1450 3.786e-10 8.809e-09
201 UROGENITAL SYSTEM DEVELOPMENT 15 299 3.82e-10 8.844e-09
202 NEGATIVE REGULATION OF BINDING 11 131 4.314e-10 9.887e-09
203 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 11 131 4.314e-10 9.887e-09
204 DIGESTIVE TRACT MORPHOGENESIS 8 48 4.378e-10 9.986e-09
205 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 12 171 5.407e-10 1.227e-08
206 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 8 50 6.167e-10 1.393e-08
207 PROTEIN COMPLEX BIOGENESIS 27 1132 6.283e-10 1.406e-08
208 PROTEIN COMPLEX ASSEMBLY 27 1132 6.283e-10 1.406e-08
209 EMBRYONIC AXIS SPECIFICATION 7 33 9.336e-10 2.079e-08
210 NEGATIVE REGULATION OF CELL CYCLE 17 433 1.037e-09 2.298e-08
211 NEGATIVE REGULATION OF PROTEIN BINDING 9 79 1.159e-09 2.556e-08
212 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 7 34 1.17e-09 2.567e-08
213 FORMATION OF PRIMARY GERM LAYER 10 110 1.27e-09 2.775e-08
214 REGULATION OF GROWTH 20 633 1.345e-09 2.924e-08
215 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 25 1008 1.382e-09 2.991e-08
216 REGULATION OF PROTEOLYSIS 21 711 1.655e-09 3.566e-08
217 REGULATION OF PROTEIN CATABOLIC PROCESS 16 393 1.993e-09 4.274e-08
218 REGULATION OF EPITHELIAL CELL PROLIFERATION 14 285 2.005e-09 4.28e-08
219 CELLULAR COMPONENT DISASSEMBLY 18 515 2.031e-09 4.314e-08
220 SKELETAL SYSTEM DEVELOPMENT 17 455 2.192e-09 4.598e-08
221 COCHLEA MORPHOGENESIS 6 21 2.18e-09 4.598e-08
222 CENTRAL NERVOUS SYSTEM DEVELOPMENT 23 872 2.194e-09 4.598e-08
223 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 11 154 2.43e-09 5.071e-08
224 MESODERM DEVELOPMENT 10 118 2.535e-09 5.266e-08
225 MESENCHYME MORPHOGENESIS 7 38 2.69e-09 5.563e-08
226 RESPIRATORY SYSTEM DEVELOPMENT 12 197 2.732e-09 5.626e-08
227 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 16 404 2.959e-09 6.065e-08
228 POSITIVE REGULATION OF CELL PROLIFERATION 22 814 3.311e-09 6.758e-08
229 POSITIVE REGULATION OF CELL CYCLE PROCESS 13 247 3.414e-09 6.937e-08
230 REGULATION OF IMMUNE SYSTEM PROCESS 29 1403 3.466e-09 6.981e-08
231 VASCULATURE DEVELOPMENT 17 469 3.453e-09 6.981e-08
232 GROWTH 16 410 3.651e-09 7.323e-08
233 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 19 602 3.704e-09 7.398e-08
234 POSITIVE REGULATION OF HYDROLASE ACTIVITY 23 905 4.437e-09 8.823e-08
235 INNER EAR MORPHOGENESIS 9 92 4.581e-09 9.071e-08
236 LEUKOCYTE CELL CELL ADHESION 13 255 5.014e-09 9.885e-08
237 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 20 684 5.038e-09 9.892e-08
238 REGULATION OF APOPTOTIC SIGNALING PATHWAY 15 363 5.416e-09 1.059e-07
239 REGULATION OF PHOSPHATASE ACTIVITY 10 128 5.61e-09 1.092e-07
240 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 8 67 6.877e-09 1.333e-07
241 CELLULAR RESPONSE TO ABIOTIC STIMULUS 13 263 7.264e-09 1.402e-07
242 RESPONSE TO DRUG 16 431 7.416e-09 1.426e-07
243 CELLULAR RESPONSE TO EXTERNAL STIMULUS 13 264 7.602e-09 1.456e-07
244 POSITIVE REGULATION OF TRANSPORT 23 936 8.355e-09 1.593e-07
245 REGULATION OF MAP KINASE ACTIVITY 14 319 8.476e-09 1.61e-07
246 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 6 26 9.025e-09 1.707e-07
247 REGULATION OF CELL CYCLE PHASE TRANSITION 14 321 9.175e-09 1.728e-07
248 RESPONSE TO ABIOTIC STIMULUS 24 1024 9.388e-09 1.761e-07
249 EYE MORPHOGENESIS 10 136 1.01e-08 1.886e-07
250 RESPONSE TO CYTOKINE 20 714 1.037e-08 1.931e-07
251 DEVELOPMENTAL INDUCTION 6 27 1.155e-08 2.132e-07
252 AXIS ELONGATION 6 27 1.155e-08 2.132e-07
253 STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 9 103 1.252e-08 2.302e-07
254 MACROMOLECULAR COMPLEX ASSEMBLY 28 1398 1.365e-08 2.5e-07
255 REGULATION OF CELL GROWTH 15 391 1.465e-08 2.673e-07
256 REGULATION OF CATABOLIC PROCESS 20 731 1.536e-08 2.793e-07
257 FAT CELL DIFFERENTIATION 9 106 1.613e-08 2.921e-07
258 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 8 77 2.11e-08 3.805e-07
259 MUSCLE CELL DIFFERENTIATION 12 237 2.175e-08 3.908e-07
260 RENAL TUBULE DEVELOPMENT 8 78 2.339e-08 4.186e-07
261 EAR MORPHOGENESIS 9 112 2.619e-08 4.651e-07
262 REGULATION OF OSTEOBLAST DIFFERENTIATION 9 112 2.619e-08 4.651e-07
263 MAMMARY GLAND EPITHELIUM DEVELOPMENT 7 53 3.048e-08 5.373e-07
264 MESONEPHRIC TUBULE MORPHOGENESIS 7 53 3.048e-08 5.373e-07
265 NEPHRON DEVELOPMENT 9 115 3.301e-08 5.797e-07
266 REGULATION OF ORGAN FORMATION 6 32 3.449e-08 6.032e-07
267 FOREBRAIN DEVELOPMENT 14 357 3.49e-08 6.081e-07
268 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 11 199 3.531e-08 6.131e-07
269 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 9 117 3.838e-08 6.615e-07
270 MAMMARY GLAND DEVELOPMENT 9 117 3.838e-08 6.615e-07
271 POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT 6 33 4.194e-08 7.201e-07
272 REGULATION OF DEPHOSPHORYLATION 10 158 4.245e-08 7.261e-07
273 POSITIVE REGULATION OF PROTEOLYSIS 14 363 4.294e-08 7.318e-07
274 REGULATION OF CHROMATIN BINDING 5 17 4.355e-08 7.368e-07
275 ESTABLISHMENT OF TISSUE POLARITY 5 17 4.355e-08 7.368e-07
276 REGULATION OF IMMUNE RESPONSE 21 858 4.374e-08 7.374e-07
277 REGULATION OF CELL ADHESION 18 629 4.446e-08 7.469e-07
278 OUTFLOW TRACT MORPHOGENESIS 7 56 4.518e-08 7.562e-07
279 CELL CYCLE PHASE TRANSITION 12 255 4.878e-08 8.135e-07
280 REGULATION OF MESENCHYMAL CELL PROLIFERATION 6 34 5.068e-08 8.392e-07
281 BIOLOGICAL ADHESION 23 1032 5.064e-08 8.392e-07
282 EPITHELIAL CELL DIFFERENTIATION 16 495 5.113e-08 8.437e-07
283 POSITIVE REGULATION OF MAP KINASE ACTIVITY 11 207 5.289e-08 8.697e-07
284 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 9 122 5.527e-08 9.056e-07
285 INOSITOL PHOSPHATE MEDIATED SIGNALING 5 18 6e-08 9.797e-07
286 POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS 12 263 6.841e-08 1.113e-06
287 STEM CELL PROLIFERATION 7 60 7.375e-08 1.196e-06
288 SEX DIFFERENTIATION 12 266 7.743e-08 1.251e-06
289 APPENDAGE DEVELOPMENT 10 169 8.023e-08 1.287e-06
290 LIMB DEVELOPMENT 10 169 8.023e-08 1.287e-06
291 IMMUNE SYSTEM DEVELOPMENT 17 582 8.156e-08 1.304e-06
292 NEGATIVE REGULATION OF CELL GROWTH 10 170 8.482e-08 1.352e-06
293 NEPHRON EPITHELIUM DEVELOPMENT 8 93 9.422e-08 1.496e-06
294 REGULATION OF CELL SUBSTRATE ADHESION 10 173 9.998e-08 1.582e-06
295 REGULATION OF MUSCLE ADAPTATION 7 63 1.041e-07 1.642e-06
296 REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 12 274 1.069e-07 1.681e-06
297 COCHLEA DEVELOPMENT 6 39 1.199e-07 1.879e-06
298 REGULATION OF CHROMOSOME ORGANIZATION 12 278 1.251e-07 1.953e-06
299 REGULATION OF OSSIFICATION 10 178 1.306e-07 2.032e-06
300 RESPONSE TO ORGANIC CYCLIC COMPOUND 21 917 1.342e-07 2.081e-06
301 POSITIVE REGULATION OF CELL MATRIX ADHESION 6 40 1.404e-07 2.164e-06
302 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 5 21 1.405e-07 2.164e-06
303 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 15 465 1.419e-07 2.18e-06
304 LENS DEVELOPMENT IN CAMERA TYPE EYE 7 66 1.443e-07 2.209e-06
305 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 11 229 1.476e-07 2.251e-06
306 CELL CELL ADHESION 17 608 1.52e-07 2.312e-06
307 REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 10 181 1.527e-07 2.314e-06
308 IMMUNE SYSTEM PROCESS 32 1984 1.671e-07 2.524e-06
309 REGULATION OF CELL JUNCTION ASSEMBLY 7 68 1.779e-07 2.679e-06
310 CAMERA TYPE EYE MORPHOGENESIS 8 101 1.796e-07 2.696e-06
311 SOMATIC STEM CELL DIVISION 5 22 1.809e-07 2.706e-06
312 REPRODUCTION 25 1297 1.988e-07 2.965e-06
313 LOCOMOTION 23 1114 2.002e-07 2.967e-06
314 NEGATIVE REGULATION OF GROWTH 11 236 1.998e-07 2.967e-06
315 REGULATION OF MUSCLE TISSUE DEVELOPMENT 8 103 2.092e-07 3.071e-06
316 REGULATION OF CIRCADIAN RHYTHM 8 103 2.092e-07 3.071e-06
317 REGULATION OF MUSCLE ORGAN DEVELOPMENT 8 103 2.092e-07 3.071e-06
318 POSITIVE REGULATION OF GROWTH 11 238 2.175e-07 3.182e-06
319 MORPHOGENESIS OF AN EPITHELIAL SHEET 6 43 2.198e-07 3.205e-06
320 POSITIVE REGULATION OF PROTEIN IMPORT 8 104 2.255e-07 3.268e-06
321 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 8 104 2.255e-07 3.268e-06
322 PROTEIN DEPHOSPHORYLATION 10 190 2.399e-07 3.467e-06
323 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 6 44 2.532e-07 3.647e-06
324 REGULATION OF FAT CELL DIFFERENTIATION 8 106 2.614e-07 3.753e-06
325 REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 9 148 2.911e-07 4.118e-06
326 PEPTIDYL SERINE MODIFICATION 9 148 2.911e-07 4.118e-06
327 DIGESTIVE SYSTEM DEVELOPMENT 9 148 2.911e-07 4.118e-06
328 RESPONSE TO EXTERNAL STIMULUS 30 1821 2.891e-07 4.118e-06
329 POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 5 24 2.892e-07 4.118e-06
330 RESPONSE TO ALCOHOL 13 362 3.046e-07 4.295e-06
331 POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY 10 197 3.355e-07 4.716e-06
332 REGULATION OF CYTOSKELETON ORGANIZATION 15 502 3.778e-07 5.294e-06
333 REGULATION OF CELLULAR RESPONSE TO HEAT 7 76 3.855e-07 5.386e-06
334 SKELETAL SYSTEM MORPHOGENESIS 10 201 4.038e-07 5.626e-06
335 POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 4 11 4.071e-07 5.654e-06
336 IN UTERO EMBRYONIC DEVELOPMENT 12 311 4.174e-07 5.78e-06
337 REGULATION OF ACTIN FILAMENT BASED PROCESS 12 312 4.319e-07 5.928e-06
338 ANTERIOR POSTERIOR AXIS SPECIFICATION 6 48 4.316e-07 5.928e-06
339 POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 6 48 4.316e-07 5.928e-06
340 CARDIAC SEPTUM MORPHOGENESIS 6 49 4.894e-07 6.697e-06
341 REGULATION OF ADHERENS JUNCTION ORGANIZATION 6 50 5.534e-07 7.551e-06
342 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 11 262 5.663e-07 7.704e-06
343 NEGATIVE REGULATION OF LOCOMOTION 11 263 5.88e-07 7.977e-06
344 REGULATION OF FIBROBLAST PROLIFERATION 7 81 5.98e-07 8.088e-06
345 SKIN DEVELOPMENT 10 211 6.307e-07 8.506e-06
346 VENTRICULAR SEPTUM MORPHOGENESIS 5 28 6.558e-07 8.793e-06
347 MORPHOGENESIS OF A POLARIZED EPITHELIUM 5 28 6.558e-07 8.793e-06
348 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 9 166 7.676e-07 1.023e-05
349 POSITIVE REGULATION OF OSSIFICATION 7 84 7.674e-07 1.023e-05
350 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 8 122 7.7e-07 1.024e-05
351 STEM CELL DIVISION 5 29 7.886e-07 1.045e-05
352 POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION 9 167 8.073e-07 1.067e-05
353 T CELL DIFFERENTIATION 8 123 8.195e-07 1.08e-05
354 CELL CELL SIGNALING 18 767 8.284e-07 1.089e-05
355 CARDIAC SEPTUM DEVELOPMENT 7 85 8.321e-07 1.091e-05
356 WOUND HEALING 14 470 9.865e-07 1.282e-05
357 REGULATION OF KIDNEY DEVELOPMENT 6 55 9.849e-07 1.282e-05
358 RESPONSE TO UV 8 126 9.844e-07 1.282e-05
359 REGULATION OF STEM CELL PROLIFERATION 7 88 1.054e-06 1.366e-05
360 REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION 8 128 1.109e-06 1.434e-05
361 REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 5 31 1.117e-06 1.44e-05
362 LYMPHOCYTE ACTIVATION 12 342 1.138e-06 1.462e-05
363 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 8 129 1.177e-06 1.508e-05
364 REGULATION OF CELL MATRIX ADHESION 7 90 1.228e-06 1.57e-05
365 RESPONSE TO INORGANIC SUBSTANCE 14 479 1.234e-06 1.573e-05
366 LEUKOCYTE ACTIVATION 13 414 1.378e-06 1.752e-05
367 MAINTENANCE OF CELL NUMBER 8 132 1.4e-06 1.776e-05
368 REGULATION OF DEVELOPMENTAL GROWTH 11 289 1.482e-06 1.869e-05
369 APOPTOTIC SIGNALING PATHWAY 11 289 1.482e-06 1.869e-05
370 REGULATION OF DNA BINDING 7 93 1.535e-06 1.93e-05
371 REGULATION OF CYTOKINE PRODUCTION 15 563 1.587e-06 1.985e-05
372 RESPONSE TO WOUNDING 15 563 1.587e-06 1.985e-05
373 RESPONSE TO HORMONE 19 893 1.715e-06 2.139e-05
374 REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 7 95 1.772e-06 2.199e-05
375 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 7 95 1.772e-06 2.199e-05
376 REGULATION OF PROTEIN DEACETYLATION 5 34 1.804e-06 2.226e-05
377 BRAIN MORPHOGENESIS 5 34 1.804e-06 2.226e-05
378 EMBRYONIC DIGIT MORPHOGENESIS 6 61 1.832e-06 2.255e-05
379 MITOTIC CELL CYCLE CHECKPOINT 8 139 2.067e-06 2.538e-05
380 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 21 1087 2.13e-06 2.608e-05
381 BLOOD VESSEL MORPHOGENESIS 12 364 2.176e-06 2.658e-05
382 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 4 16 2.193e-06 2.671e-05
383 REGULATION OF CARTILAGE DEVELOPMENT 6 63 2.219e-06 2.689e-05
384 REGULATION OF EPIDERMIS DEVELOPMENT 6 63 2.219e-06 2.689e-05
385 PROTEIN CATABOLIC PROCESS 15 579 2.24e-06 2.708e-05
386 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 8 141 2.301e-06 2.774e-05
387 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 11 303 2.344e-06 2.819e-05
388 POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 5 36 2.42e-06 2.902e-05
389 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 7 100 2.504e-06 2.995e-05
390 POSITIVE REGULATION OF CYTOKINE PRODUCTION 12 370 2.576e-06 3.074e-05
391 CARDIAC CHAMBER DEVELOPMENT 8 144 2.694e-06 3.206e-05
392 RESPONSE TO EXTRACELLULAR STIMULUS 13 441 2.765e-06 3.282e-05
393 CONNECTIVE TISSUE DEVELOPMENT 9 194 2.799e-06 3.314e-05
394 REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS 4 17 2.854e-06 3.362e-05
395 REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 4 17 2.854e-06 3.362e-05
396 SOMATIC STEM CELL POPULATION MAINTENANCE 6 66 2.924e-06 3.419e-05
397 CELLULAR RESPONSE TO UV 6 66 2.924e-06 3.419e-05
398 EAR DEVELOPMENT 9 195 2.92e-06 3.419e-05
399 REGULATION OF PROTEIN COMPLEX ASSEMBLY 12 375 2.958e-06 3.45e-05
400 REGULATION OF GTPASE ACTIVITY 16 673 3.038e-06 3.533e-05
401 CARDIAC CHAMBER MORPHOGENESIS 7 104 3.257e-06 3.78e-05
402 MALE SEX DIFFERENTIATION 8 148 3.305e-06 3.826e-05
403 PERICARDIUM DEVELOPMENT 4 18 3.653e-06 4.197e-05
404 POST ANAL TAIL MORPHOGENESIS 4 18 3.653e-06 4.197e-05
405 UTERUS DEVELOPMENT 4 18 3.653e-06 4.197e-05
406 INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 7 106 3.7e-06 4.24e-05
407 REGULATION OF MUSCLE CELL DIFFERENTIATION 8 152 4.031e-06 4.608e-05
408 REGULATION OF MEIOTIC CELL CYCLE 5 40 4.143e-06 4.702e-05
409 NEURAL PRECURSOR CELL PROLIFERATION 6 70 4.138e-06 4.702e-05
410 REGULATION OF MEMBRANE PERMEABILITY 6 70 4.138e-06 4.702e-05
411 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 7 108 4.191e-06 4.745e-05
412 CELL DIVISION 13 460 4.378e-06 4.944e-05
413 SKIN EPIDERMIS DEVELOPMENT 6 71 4.497e-06 5.067e-05
414 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 4 19 4.605e-06 5.176e-05
415 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 5 41 4.696e-06 5.265e-05
416 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 8 156 4.887e-06 5.466e-05
417 POSITIVE REGULATION OF CATABOLIC PROCESS 12 395 5.032e-06 5.615e-05
418 LYMPHOCYTE DIFFERENTIATION 9 209 5.144e-06 5.726e-05
419 GENITALIA DEVELOPMENT 5 42 5.305e-06 5.891e-05
420 NEURON PROJECTION DEVELOPMENT 14 545 5.511e-06 6.105e-05
421 TONGUE DEVELOPMENT 4 20 5.73e-06 6.303e-05
422 TRACHEA DEVELOPMENT 4 20 5.73e-06 6.303e-05
423 POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 4 20 5.73e-06 6.303e-05
424 RESPONSE TO METAL ION 11 333 5.785e-06 6.348e-05
425 REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 5 43 5.974e-06 6.54e-05
426 REGULATION OF NEURON DIFFERENTIATION 14 554 6.641e-06 7.254e-05
427 LABYRINTHINE LAYER DEVELOPMENT 5 44 6.707e-06 7.309e-05
428 REGULATION OF MITOCHONDRION ORGANIZATION 9 218 7.236e-06 7.83e-05
429 REGULATION OF CELL PROJECTION ORGANIZATION 14 558 7.206e-06 7.83e-05
430 REGULATION OF BMP SIGNALING PATHWAY 6 77 7.228e-06 7.83e-05
431 THYMOCYTE AGGREGATION 5 45 7.509e-06 8.088e-05
432 T CELL DIFFERENTIATION IN THYMUS 5 45 7.509e-06 8.088e-05
433 REGULATION OF PROTEIN STABILITY 9 221 8.079e-06 8.682e-05
434 PEPTIDYL THREONINE MODIFICATION 5 46 8.385e-06 8.989e-05
435 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 7 121 8.896e-06 9.516e-05
436 POSITIVE REGULATION OF LOCOMOTION 12 420 9.353e-06 9.981e-05
437 DEPHOSPHORYLATION 10 286 9.568e-06 0.0001019
438 SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 4 23 1.033e-05 0.0001097
439 JNK CASCADE 6 82 1.042e-05 0.0001104
440 HAIR CYCLE 6 83 1.117e-05 0.0001179
441 MOLTING CYCLE 6 83 1.117e-05 0.0001179
442 POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION 8 175 1.137e-05 0.0001197
443 LEUKOCYTE DIFFERENTIATION 10 292 1.146e-05 0.0001204
444 OSTEOBLAST DIFFERENTIATION 7 126 1.16e-05 0.0001216
445 REGULATION OF HISTONE DEACETYLATION 4 24 1.233e-05 0.0001287
446 POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 4 24 1.233e-05 0.0001287
447 MUSCLE CELL DEVELOPMENT 7 128 1.286e-05 0.0001339
448 REGULATION OF REPRODUCTIVE PROCESS 7 129 1.353e-05 0.0001405
449 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 12 437 1.39e-05 0.000144
450 POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 5 51 1.403e-05 0.000145
451 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 11 368 1.478e-05 0.0001525
452 NEGATIVE REGULATION OF CELL DEVELOPMENT 10 303 1.578e-05 0.0001625
453 RESPONSE TO NITROGEN COMPOUND 17 859 1.637e-05 0.0001682
454 EPITHELIAL CELL PROLIFERATION 6 89 1.67e-05 0.0001712
455 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 5 53 1.697e-05 0.0001735
456 NEURON DEVELOPMENT 15 687 1.737e-05 0.0001773
457 EPITHELIAL CELL DEVELOPMENT 8 186 1.769e-05 0.0001801
458 CALCIUM MEDIATED SIGNALING 6 90 1.781e-05 0.0001805
459 ENDOTHELIUM DEVELOPMENT 6 90 1.781e-05 0.0001805
460 POSITIVE REGULATION OF CELL ADHESION 11 376 1.804e-05 0.0001825
461 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 17 867 1.844e-05 0.0001861
462 VENTRICULAR SEPTUM DEVELOPMENT 5 54 1.861e-05 0.0001875
463 CELLULAR RESPONSE TO LIGHT STIMULUS 6 91 1.897e-05 0.0001906
464 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 8 188 1.911e-05 0.0001916
465 RESPONSE TO OXYGEN LEVELS 10 311 1.974e-05 0.0001976
466 CELLULAR RESPONSE TO RADIATION 7 137 2.001e-05 0.0001997
467 RESPONSE TO LITHIUM ION 4 27 2.009e-05 0.0001997
468 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 4 27 2.009e-05 0.0001997
469 MITOCHONDRIAL MEMBRANE ORGANIZATION 6 92 2.019e-05 0.0002003
470 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 8 190 2.062e-05 0.0002042
471 CELL CYCLE G2 M PHASE TRANSITION 7 138 2.098e-05 0.0002068
472 PLACENTA DEVELOPMENT 7 138 2.098e-05 0.0002068
473 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 6 93 2.148e-05 0.0002113
474 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 14 616 2.178e-05 0.0002138
475 POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 8 192 2.224e-05 0.0002173
476 OSSIFICATION 9 251 2.228e-05 0.0002173
477 PROTEIN AUTOPHOSPHORYLATION 8 192 2.224e-05 0.0002173
478 GASTRULATION WITH MOUTH FORMING SECOND 4 28 2.332e-05 0.000227
479 EPIDERMIS DEVELOPMENT 9 253 2.372e-05 0.0002304
480 PROTEIN LOCALIZATION 26 1805 2.396e-05 0.0002318
481 CELL CYCLE CHECKPOINT 8 194 2.395e-05 0.0002318
482 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 13 541 2.454e-05 0.0002364
483 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 13 541 2.454e-05 0.0002364
484 TAXIS 12 464 2.511e-05 0.0002414
485 REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY 4 29 2.693e-05 0.0002573
486 POSITIVE REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY 4 29 2.693e-05 0.0002573
487 REGULATION OF HEART MORPHOGENESIS 4 29 2.693e-05 0.0002573
488 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 7 144 2.76e-05 0.0002632
489 SYNAPSE ORGANIZATION 7 145 2.886e-05 0.0002746
490 NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION 7 146 3.016e-05 0.0002864
491 CELL PROJECTION ORGANIZATION 17 902 3.047e-05 0.0002887
492 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 6 99 3.066e-05 0.00029
493 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 5 60 3.123e-05 0.0002947
494 CARTILAGE DEVELOPMENT 7 147 3.151e-05 0.0002962
495 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 7 147 3.151e-05 0.0002962
496 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 15 724 3.19e-05 0.0002992
497 POSITIVE REGULATION OF CELL GROWTH 7 148 3.292e-05 0.0003082
498 NEURON PROJECTION MORPHOGENESIS 11 402 3.332e-05 0.0003113
499 POSITIVE REGULATION OF STEM CELL PROLIFERATION 5 61 3.385e-05 0.0003156
500 ENDOTHELIAL TUBE MORPHOGENESIS 3 11 3.44e-05 0.0003195
501 POSITIVE REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS 3 11 3.44e-05 0.0003195
502 NEURON PROJECTION GUIDANCE 8 205 3.552e-05 0.0003292
503 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 6 102 3.631e-05 0.0003358
504 PROTEOLYSIS 20 1208 3.65e-05 0.000337
505 REGULATION OF SMOOTHENED SIGNALING PATHWAY 5 62 3.664e-05 0.0003376
506 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 8 207 3.806e-05 0.0003498
507 REGULATION OF NEURON PROJECTION DEVELOPMENT 11 408 3.812e-05 0.0003498
508 REGULATION OF CHROMATIN ORGANIZATION 7 152 3.904e-05 0.0003576
509 EMBRYONIC FORELIMB MORPHOGENESIS 4 32 4.021e-05 0.0003675
510 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 8 209 4.074e-05 0.000371
511 PALLIUM DEVELOPMENT 7 153 4.071e-05 0.000371
512 REGULATION OF CELL DIVISION 9 272 4.177e-05 0.0003796
513 RESPONSE TO MECHANICAL STIMULUS 8 210 4.215e-05 0.0003823
514 CELL CYCLE ARREST 7 154 4.244e-05 0.0003841
515 RESPONSE TO RADIATION 11 413 4.256e-05 0.0003845
516 POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION 3 12 4.567e-05 0.0004094
517 TRACHEA MORPHOGENESIS 3 12 4.567e-05 0.0004094
518 EMBRYONIC EYE MORPHOGENESIS 4 33 4.554e-05 0.0004094
519 MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 3 12 4.567e-05 0.0004094
520 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 8 213 4.66e-05 0.0004169
521 PEPTIDYL AMINO ACID MODIFICATION 16 841 4.766e-05 0.0004256
522 MUSCLE ORGAN DEVELOPMENT 9 277 4.811e-05 0.0004285
523 NEGATIVE REGULATION OF CELL CYCLE PROCESS 8 214 4.816e-05 0.0004285
524 CELLULAR MACROMOLECULE LOCALIZATION 20 1234 4.92e-05 0.0004369
525 FOREBRAIN GENERATION OF NEURONS 5 66 4.964e-05 0.00044
526 PROTEIN DESTABILIZATION 4 34 5.137e-05 0.0004544
527 RESPONSE TO LIGHT STIMULUS 9 280 5.228e-05 0.0004616
528 REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS 5 67 5.339e-05 0.0004687
529 CELLULAR RESPONSE TO DRUG 5 67 5.339e-05 0.0004687
530 REGULATION OF SISTER CHROMATID SEGREGATION 5 67 5.339e-05 0.0004687
531 SECOND MESSENGER MEDIATED SIGNALING 7 160 5.411e-05 0.0004741
532 BONE REMODELING 4 35 5.773e-05 0.0005049
533 CELL CYCLE G1 S PHASE TRANSITION 6 111 5.841e-05 0.000509
534 G1 S TRANSITION OF MITOTIC CELL CYCLE 6 111 5.841e-05 0.000509
535 WHITE FAT CELL DIFFERENTIATION 3 13 5.91e-05 0.0005102
536 HEMATOPOIETIC STEM CELL PROLIFERATION 3 13 5.91e-05 0.0005102
537 REGULATION OF SKELETAL MUSCLE ADAPTATION 3 13 5.91e-05 0.0005102
538 REGULATION OF CELL FATE SPECIFICATION 3 13 5.91e-05 0.0005102
539 REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 3 13 5.91e-05 0.0005102
540 CELLULAR RESPONSE TO BIOTIC STIMULUS 7 163 6.086e-05 0.0005244
541 POSITIVE REGULATION OF AXONOGENESIS 5 69 6.153e-05 0.0005282
542 SYNAPSE ASSEMBLY 5 69 6.153e-05 0.0005282
543 HEAD MORPHOGENESIS 4 36 6.464e-05 0.0005539
544 MUSCLE ORGAN MORPHOGENESIS 5 70 6.594e-05 0.000564
545 REGULATION OF ENDOTHELIAL CELL MIGRATION 6 114 6.779e-05 0.0005788
546 REGULATION OF EPITHELIAL CELL MIGRATION 7 166 6.829e-05 0.0005819
547 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 5 71 7.06e-05 0.0005994
548 ENDODERM DEVELOPMENT 5 71 7.06e-05 0.0005994
549 CELLULAR RESPONSE TO ALCOHOL 6 115 7.117e-05 0.0006021
550 RESPONSE TO CALCIUM ION 6 115 7.117e-05 0.0006021
551 REGULATION OF MUSCLE HYPERTROPHY 4 37 7.214e-05 0.0006092
552 REGULATION OF AXONOGENESIS 7 168 7.364e-05 0.0006207
553 ANGIOGENESIS 9 293 7.41e-05 0.0006235
554 POSITIVE REGULATION OF MEIOTIC CELL CYCLE 3 14 7.489e-05 0.0006267
555 EMBRYONIC SKELETAL JOINT DEVELOPMENT 3 14 7.489e-05 0.0006267
556 REGULATION OF MONOCYTE DIFFERENTIATION 3 14 7.489e-05 0.0006267
557 TELENCEPHALON DEVELOPMENT 8 228 7.516e-05 0.0006279
558 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 20 1275 7.738e-05 0.0006452
559 SPECIFICATION OF SYMMETRY 6 117 7.834e-05 0.0006499
560 CELLULAR RESPONSE TO CYTOKINE STIMULUS 13 606 7.836e-05 0.0006499
561 CELLULAR RESPONSE TO STARVATION 6 117 7.834e-05 0.0006499
562 POSITIVE REGULATION OF PROTEIN BINDING 5 73 8.067e-05 0.0006655
563 PANCREAS DEVELOPMENT 5 73 8.067e-05 0.0006655
564 EMBRYONIC HEART TUBE DEVELOPMENT 5 73 8.067e-05 0.0006655
565 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 8 232 8.485e-05 0.0006976
566 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 8 232 8.485e-05 0.0006976
567 REGULATION OF VASCULATURE DEVELOPMENT 8 233 8.743e-05 0.0007175
568 STRIATED MUSCLE CELL DIFFERENTIATION 7 173 8.853e-05 0.0007252
569 NEURAL CREST CELL DIFFERENTIATION 5 75 9.18e-05 0.0007507
570 NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS 3 15 9.32e-05 0.0007595
571 REGULATION OF MESODERM DEVELOPMENT 3 15 9.32e-05 0.0007595
572 FORELIMB MORPHOGENESIS 4 40 9.844e-05 0.0008007
573 MITOCHONDRIAL TRANSPORT 7 177 0.0001021 0.0008294
574 NEGATIVE REGULATION OF TRANSPORT 11 458 0.0001071 0.0008684
575 MORPHOGENESIS OF AN ENDOTHELIUM 3 16 0.0001142 0.0009209
576 ORGAN INDUCTION 3 16 0.0001142 0.0009209
577 APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 3 16 0.0001142 0.0009209
578 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 4 42 0.0001194 0.0009598
579 EPITHELIAL CELL MORPHOGENESIS 4 42 0.0001194 0.0009598
580 CHROMOSOME ORGANIZATION 17 1009 0.0001212 0.0009726
581 POSITIVE REGULATION OF BINDING 6 127 0.0001233 0.0009873
582 CELLULAR RESPONSE TO MECHANICAL STIMULUS 5 80 0.0001248 0.000998
583 REGULATION OF MYELOID CELL DIFFERENTIATION 7 183 0.0001257 0.001003
584 POSITIVE REGULATION OF INNATE IMMUNE RESPONSE 8 246 0.0001273 0.001014
585 HEPATICOBILIARY SYSTEM DEVELOPMENT 6 128 0.0001287 0.001024
586 REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 4 43 0.0001311 0.001039
587 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 4 43 0.0001311 0.001039
588 CELLULAR RESPONSE TO HORMONE STIMULUS 12 552 0.0001322 0.001046
589 METANEPHROS DEVELOPMENT 5 81 0.0001324 0.001046
590 CELL JUNCTION ORGANIZATION 7 185 0.0001345 0.00106
591 CELLULAR RESPONSE TO LITHIUM ION 3 17 0.0001381 0.001085
592 NEGATIVE REGULATION OF STEM CELL PROLIFERATION 3 17 0.0001381 0.001085
593 BODY MORPHOGENESIS 4 44 0.0001435 0.001126
594 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 15 829 0.0001455 0.00114
595 MACROMOLECULE CATABOLIC PROCESS 16 926 0.0001466 0.001146
596 EMBRYONIC PLACENTA DEVELOPMENT 5 83 0.0001486 0.00116
597 REGULATION OF HORMONE LEVELS 11 478 0.0001557 0.001214
598 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 5 84 0.0001573 0.001219
599 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 5 84 0.0001573 0.001219
600 CELL MOTILITY 15 835 0.0001574 0.001219
601 LOCALIZATION OF CELL 15 835 0.0001574 0.001219
602 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 7 191 0.0001638 0.001266
603 REGULATION OF CELL MATURATION 3 18 0.0001649 0.001273
604 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 5 85 0.0001663 0.001277
605 REGULATION OF CHROMOSOME SEGREGATION 5 85 0.0001663 0.001277
606 POSITIVE REGULATION OF CHROMATIN MODIFICATION 5 85 0.0001663 0.001277
607 REGULATION OF PEPTIDE TRANSPORT 8 256 0.0001673 0.001283
608 REGULATION OF CHONDROCYTE DIFFERENTIATION 4 46 0.0001709 0.001306
609 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 4 46 0.0001709 0.001306
610 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 6 135 0.0001723 0.001314
611 NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 6 136 0.0001793 0.001366
612 REGULATION OF MUSCLE SYSTEM PROCESS 7 195 0.0001861 0.001412
613 POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 4 47 0.0001859 0.001412
614 CHROMATIN ORGANIZATION 13 663 0.0001909 0.001447
615 REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 3 19 0.000195 0.001473
616 POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS 3 19 0.000195 0.001473
617 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 4 48 0.0002019 0.001523
618 RESPONSE TO STEROID HORMONE 11 497 0.0002181 0.001642
619 PLATELET ACTIVATION 6 142 0.0002267 0.001704
620 REGULATION OF DNA METABOLIC PROCESS 9 340 0.000227 0.001704
621 METANEPHRIC EPITHELIUM DEVELOPMENT 3 20 0.0002284 0.001709
622 BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS 3 20 0.0002284 0.001709
623 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 4 50 0.0002368 0.001754
624 CELLULAR RESPONSE TO OXYGEN LEVELS 6 143 0.0002355 0.001754
625 RAS PROTEIN SIGNAL TRANSDUCTION 6 143 0.0002355 0.001754
626 FACE DEVELOPMENT 4 50 0.0002368 0.001754
627 POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 4 50 0.0002368 0.001754
628 RHO PROTEIN SIGNAL TRANSDUCTION 4 50 0.0002368 0.001754
629 ACTIVATION OF INNATE IMMUNE RESPONSE 7 204 0.0002452 0.001814
630 NEGATIVE REGULATION OF PHOSPHORYLATION 10 422 0.0002478 0.00183
631 CELLULAR RESPONSE TO NITROGEN COMPOUND 11 505 0.0002501 0.001844
632 COVALENT CHROMATIN MODIFICATION 9 345 0.0002529 0.001862
633 RESPONSE TO ESTRADIOL 6 146 0.0002634 0.001936
634 APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 3 21 0.0002653 0.001944
635 BONE RESORPTION 3 21 0.0002653 0.001944
636 POSITIVE REGULATION OF REPRODUCTIVE PROCESS 4 52 0.0002757 0.002017
637 NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 5 95 0.0002799 0.002045
638 G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 18 1193 0.0002958 0.002157
639 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 4 53 0.0002969 0.002162
640 MODULATION OF TRANSCRIPTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 3 22 0.0003058 0.002213
641 POSITIVE REGULATION OF MUSCLE HYPERTROPHY 3 22 0.0003058 0.002213
642 POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY 3 22 0.0003058 0.002213
643 EMBRYONIC PLACENTA MORPHOGENESIS 3 22 0.0003058 0.002213
644 PROTEIN LOCALIZATION TO CELL PERIPHERY 6 151 0.0003157 0.002281
645 REGULATION OF SECRETION 13 699 0.0003182 0.002296
646 POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 5 98 0.0003234 0.002329
647 INTRINSIC APOPTOTIC SIGNALING PATHWAY 6 152 0.0003271 0.002352
648 CRANIAL SKELETAL SYSTEM DEVELOPMENT 4 55 0.0003425 0.00246
649 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 7 216 0.0003468 0.002486
650 AMEBOIDAL TYPE CELL MIGRATION 6 154 0.0003508 0.002499
651 REGULATION OF OSTEOBLAST PROLIFERATION 3 23 0.0003502 0.002499
652 REGULATION OF METANEPHROS DEVELOPMENT 3 23 0.0003502 0.002499
653 RESPONSE TO STARVATION 6 154 0.0003508 0.002499
654 RESPONSE TO ESTROGEN 7 218 0.0003666 0.002608
655 SMAD PROTEIN SIGNAL TRANSDUCTION 4 56 0.0003672 0.002608
656 REGULATION OF EXTENT OF CELL GROWTH 5 101 0.0003718 0.002637
657 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 6 156 0.0003758 0.002661
658 MYOTUBE DIFFERENTIATION 4 57 0.0003931 0.002775
659 APOPTOTIC MITOCHONDRIAL CHANGES 4 57 0.0003931 0.002775
660 EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 3 24 0.0003984 0.002805
661 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 3 24 0.0003984 0.002805
662 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 5 103 0.000407 0.002861
663 PROTEIN ACYLATION 6 159 0.0004159 0.002919
664 CHROMATIN MODIFICATION 11 539 0.0004342 0.003043
665 REGENERATION 6 161 0.0004445 0.003097
666 CEREBRAL CORTEX DEVELOPMENT 5 105 0.0004447 0.003097
667 REGULATION OF DNA REPLICATION 6 161 0.0004445 0.003097
668 ODONTOGENESIS 5 105 0.0004447 0.003097
669 LENS FIBER CELL DIFFERENTIATION 3 25 0.0004508 0.003103
670 SPINDLE CHECKPOINT 3 25 0.0004508 0.003103
671 FOREBRAIN REGIONALIZATION 3 25 0.0004508 0.003103
672 REGULATION OF CELL CYCLE G2 M PHASE TRANSITION 4 59 0.0004487 0.003103
673 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 3 25 0.0004508 0.003103
674 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 3 25 0.0004508 0.003103
675 POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 3 25 0.0004508 0.003103
676 VASCULOGENESIS 4 59 0.0004487 0.003103
677 REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 6 162 0.0004593 0.003157
678 CELL PART MORPHOGENESIS 12 633 0.0004603 0.003159
679 CARDIAC VENTRICLE DEVELOPMENT 5 106 0.0004644 0.003183
680 REGULATION OF NUCLEAR DIVISION 6 163 0.0004746 0.003247
681 NEGATIVE REGULATION OF CELL DIVISION 4 60 0.0004785 0.003265
682 CHONDROCYTE DIFFERENTIATION 4 60 0.0004785 0.003265
683 CELL SUBSTRATE ADHESION 6 164 0.0004902 0.003339
684 MODULATION OF SYNAPTIC TRANSMISSION 8 301 0.0004962 0.003376
685 DEVELOPMENTAL PROGRAMMED CELL DEATH 3 26 0.0005073 0.003431
686 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 3 26 0.0005073 0.003431
687 REGULATION OF CELL CYCLE ARREST 5 108 0.000506 0.003431
688 REGULATION OF CELL FATE COMMITMENT 3 26 0.0005073 0.003431
689 REGULATION OF CELL CELL ADHESION 9 380 0.000511 0.003451
690 NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS 5 109 0.0005278 0.003554
691 RESPONSE TO HYDROGEN PEROXIDE 5 109 0.0005278 0.003554
692 REGULATION OF LEUKOCYTE DIFFERENTIATION 7 232 0.0005319 0.003576
693 EMBRYONIC HEART TUBE MORPHOGENESIS 4 62 0.0005423 0.003641
694 RESPONSE TO ENDOPLASMIC RETICULUM STRESS 7 233 0.0005457 0.003658
695 POSITIVE REGULATION OF NEURON DIFFERENTIATION 8 306 0.000553 0.003702
696 SKELETAL MUSCLE TISSUE REGENERATION 3 27 0.0005682 0.003782
697 REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 3 27 0.0005682 0.003782
698 NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION 3 27 0.0005682 0.003782
699 NEGATIVE REGULATION OF AXON GUIDANCE 3 27 0.0005682 0.003782
700 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 5 111 0.0005735 0.003812
701 NEUROEPITHELIAL CELL DIFFERENTIATION 4 63 0.0005764 0.003826
702 REGULATION OF SYNAPSE ORGANIZATION 5 113 0.0006221 0.004123
703 POSITIVE REGULATION OF IMMUNE RESPONSE 11 563 0.0006237 0.004128
704 PLACENTA BLOOD VESSEL DEVELOPMENT 3 28 0.0006336 0.004158
705 NEGATIVE REGULATION OF CHROMOSOME SEGREGATION 3 28 0.0006336 0.004158
706 NEGATIVE REGULATION OF DENDRITE DEVELOPMENT 3 28 0.0006336 0.004158
707 REGULATION OF CELL SIZE 6 172 0.0006301 0.004158
708 MAMMARY GLAND DUCT MORPHOGENESIS 3 28 0.0006336 0.004158
709 METANEPHROS MORPHOGENESIS 3 28 0.0006336 0.004158
710 NEGATIVE REGULATION OF AXONOGENESIS 4 65 0.0006491 0.004254
711 RESPONSE TO INTERLEUKIN 1 5 115 0.0006737 0.004409
712 INTERSPECIES INTERACTION BETWEEN ORGANISMS 12 662 0.0006834 0.00446
713 SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 12 662 0.0006834 0.00446
714 REGULATION OF MICROTUBULE BASED PROCESS 7 243 0.0006996 0.004559
715 FEMALE SEX DIFFERENTIATION 5 116 0.0007007 0.00456
716 REGULATION OF MEIOTIC NUCLEAR DIVISION 3 29 0.0007036 0.004566
717 EMBRYONIC HINDLIMB MORPHOGENESIS 3 29 0.0007036 0.004566
718 POSITIVE REGULATION OF NEURON DEATH 4 67 0.0007281 0.004708
719 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 5 117 0.0007285 0.004708
720 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 4 67 0.0007281 0.004708
721 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 5 118 0.0007571 0.004886
722 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 4 68 0.00077 0.004955
723 POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION 4 68 0.00077 0.004955
724 INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR 3 30 0.0007784 0.004961
725 ESTABLISHMENT OR MAINTENANCE OF EPITHELIAL CELL APICAL BASAL POLARITY 3 30 0.0007784 0.004961
726 SMOOTH MUSCLE CELL DIFFERENTIATION 3 30 0.0007784 0.004961
727 POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 3 30 0.0007784 0.004961
728 ESTABLISHMENT OF ENDOTHELIAL BARRIER 3 30 0.0007784 0.004961
729 RESPONSE TO X RAY 3 30 0.0007784 0.004961
730 MYOTUBE CELL DEVELOPMENT 3 30 0.0007784 0.004961
731 REGULATION OF CHEMOTAXIS 6 180 0.0007991 0.005086
732 RESPONSE TO KETONE 6 182 0.0008464 0.00538
733 INTERFERON GAMMA MEDIATED SIGNALING PATHWAY 4 70 0.0008589 0.005452
734 CELLULAR RESPONSE TO INTERFERON GAMMA 5 122 0.0008799 0.005578
735 CATABOLIC PROCESS 22 1773 0.0008999 0.005697
736 INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 4 71 0.000906 0.005727
737 POSITIVE REGULATION OF MITOTIC CELL CYCLE 5 123 0.0009128 0.005763
738 PATTERNING OF BLOOD VESSELS 3 32 0.0009426 0.005927
739 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA 3 32 0.0009426 0.005927
740 POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT 3 32 0.0009426 0.005927
741 ENDOTHELIAL CELL DIFFERENTIATION 4 72 0.0009548 0.005996
742 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 12 689 0.0009667 0.006062
743 G1 DNA DAMAGE CHECKPOINT 4 73 0.001005 0.006288
744 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 4 73 0.001005 0.006288
745 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 5 126 0.001017 0.006352
746 REGULATION OF PROTEIN EXPORT FROM NUCLEUS 3 33 0.001032 0.006439
747 REGULATION OF DENDRITE MORPHOGENESIS 4 74 0.001058 0.006573
748 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 4 74 0.001058 0.006573
749 CELL CELL JUNCTION ASSEMBLY 4 74 0.001058 0.006573
750 MEMBRANE ORGANIZATION 14 899 0.00108 0.0067
751 REGULATION OF HORMONE SECRETION 7 262 0.001086 0.006726
752 PROTEIN ACETYLATION 5 129 0.00113 0.006972
753 NEGATIVE REGULATION OF MITOTIC NUCLEAR DIVISION 3 34 0.001127 0.006972
754 CELL JUNCTION ASSEMBLY 5 129 0.00113 0.006972
755 ACTIVATION OF IMMUNE RESPONSE 9 427 0.001165 0.00718
756 PROTEIN STABILIZATION 5 131 0.00121 0.007448
757 REGULATION OF GASTRULATION 3 35 0.001227 0.007505
758 DIENCEPHALON DEVELOPMENT 4 77 0.001227 0.007505
759 RESPONSE TO MINERALOCORTICOID 3 35 0.001227 0.007505
760 EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 3 35 0.001227 0.007505
761 INNER EAR RECEPTOR CELL DEVELOPMENT 3 35 0.001227 0.007505
762 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 4 78 0.001288 0.007862
763 T CELL PROLIFERATION 3 36 0.001333 0.008098
764 NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT 3 36 0.001333 0.008098
765 NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 3 36 0.001333 0.008098
766 POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 3 36 0.001333 0.008098
767 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 8 352 0.001364 0.008276
768 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 4 80 0.001414 0.008569
769 MUSCLE TISSUE DEVELOPMENT 7 275 0.001434 0.008661
770 HINDLIMB MORPHOGENESIS 3 37 0.001444 0.008661
771 REGULATION OF RECEPTOR INTERNALIZATION 3 37 0.001444 0.008661
772 MYOBLAST DIFFERENTIATION 3 37 0.001444 0.008661
773 REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 3 37 0.001444 0.008661
774 NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 3 37 0.001444 0.008661
775 ESTABLISHMENT OR MAINTENANCE OF APICAL BASAL CELL POLARITY 3 37 0.001444 0.008661
776 ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY 3 37 0.001444 0.008661
777 CIRCADIAN RHYTHM 5 137 0.001476 0.008827
778 HINDBRAIN DEVELOPMENT 5 137 0.001476 0.008827
779 POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 4 81 0.001481 0.008846
780 PLASMA MEMBRANE ORGANIZATION 6 203 0.001484 0.008852
781 REGULATION OF INNATE IMMUNE RESPONSE 8 357 0.001491 0.008885
782 NEGATIVE REGULATION OF AXON EXTENSION 3 38 0.001561 0.009255
783 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 3 38 0.001561 0.009255
784 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 3 38 0.001561 0.009255
785 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 3 38 0.001561 0.009255
786 REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 7 280 0.00159 0.009411
787 NIK NF KAPPAB SIGNALING 4 83 0.001621 0.009582
788 REGULATION OF SYNAPTIC PLASTICITY 5 140 0.001624 0.009589
789 POSITIVE REGULATION OF VIRAL TRANSCRIPTION 3 39 0.001684 0.009898
790 REGULATION OF AXON GUIDANCE 3 39 0.001684 0.009898
791 TRABECULA MORPHOGENESIS 3 39 0.001684 0.009898
792 POSITIVE REGULATION OF DEFENSE RESPONSE 8 364 0.001685 0.009898
NumGOOverlapSizeP ValueAdj. P Value
1 FRIZZLED BINDING 20 36 5.593e-36 5.196e-33
2 WNT PROTEIN BINDING 15 31 6.011e-26 2.792e-23
3 WNT ACTIVATED RECEPTOR ACTIVITY 13 22 3.56e-24 1.102e-21
4 BETA CATENIN BINDING 16 84 5.237e-20 1.216e-17
5 G PROTEIN COUPLED RECEPTOR BINDING 20 259 9.274e-17 1.723e-14
6 ENZYME BINDING 41 1737 6.642e-15 1.028e-12
7 TRANSCRIPTION FACTOR BINDING 23 524 7.934e-14 1.053e-11
8 PROTEIN SERINE THREONINE KINASE ACTIVITY 21 445 2.699e-13 3.134e-11
9 PROTEIN DOMAIN SPECIFIC BINDING 24 624 3.725e-13 3.845e-11
10 RECEPTOR BINDING 35 1476 1.03e-12 9.568e-11
11 RECEPTOR AGONIST ACTIVITY 7 16 2.722e-12 2.107e-10
12 MOLECULAR FUNCTION REGULATOR 33 1353 2.56e-12 2.107e-10
13 SIGNAL TRANSDUCER ACTIVITY 37 1731 4.278e-12 3.057e-10
14 PROTEIN PHOSPHATASE TYPE 2A REGULATOR ACTIVITY 7 21 2.698e-11 1.79e-09
15 PROTEIN KINASE ACTIVITY 22 640 3.604e-11 2.232e-09
16 UBIQUITIN LIKE PROTEIN LIGASE BINDING 15 264 6.706e-11 3.894e-09
17 RECEPTOR REGULATOR ACTIVITY 8 45 2.539e-10 1.387e-08
18 SMAD BINDING 9 72 4.965e-10 2.563e-08
19 RECEPTOR ACTIVATOR ACTIVITY 7 32 7.393e-10 3.615e-08
20 I SMAD BINDING 5 11 3.347e-09 1.555e-07
21 REGULATORY REGION NUCLEIC ACID BINDING 22 818 3.622e-09 1.602e-07
22 KINASE BINDING 19 606 4.127e-09 1.743e-07
23 KINASE ACTIVITY 22 842 6.134e-09 2.478e-07
24 ARMADILLO REPEAT DOMAIN BINDING 5 13 9.234e-09 3.574e-07
25 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 9 104 1.364e-08 5.067e-07
26 CORE PROMOTER PROXIMAL REGION DNA BINDING 14 371 5.627e-08 1.936e-06
27 PHOSPHATASE REGULATOR ACTIVITY 8 87 5.572e-08 1.936e-06
28 PDZ DOMAIN BINDING 8 90 7.281e-08 2.416e-06
29 PROTEIN DIMERIZATION ACTIVITY 24 1149 8.346e-08 2.674e-06
30 PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY 7 64 1.163e-07 3.485e-06
31 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 22 992 1.128e-07 3.485e-06
32 R SMAD BINDING 5 23 2.3e-07 6.678e-06
33 ENZYME REGULATOR ACTIVITY 21 959 2.821e-07 7.94e-06
34 MAP KINASE ACTIVITY 4 14 1.218e-06 3.24e-05
35 ACTIVATING TRANSCRIPTION FACTOR BINDING 6 57 1.221e-06 3.24e-05
36 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 16 629 1.269e-06 3.275e-05
37 CALMODULIN BINDING 9 179 1.44e-06 3.616e-05
38 RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING 5 36 2.42e-06 5.916e-05
39 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 15 588 2.706e-06 6.445e-05
40 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 11 315 3.406e-06 7.911e-05
41 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 11 328 5.011e-06 0.0001135
42 RHO GTPASE BINDING 6 78 7.792e-06 0.0001724
43 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 21 1199 9.738e-06 0.0002056
44 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 9 226 9.671e-06 0.0002056
45 RECEPTOR SIGNALING PROTEIN ACTIVITY 8 172 1.002e-05 0.0002069
46 IDENTICAL PROTEIN BINDING 21 1209 1.105e-05 0.0002231
47 PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 8 178 1.286e-05 0.0002543
48 CHROMATIN BINDING 12 435 1.328e-05 0.000257
49 PHOSPHORIC ESTER HYDROLASE ACTIVITY 11 368 1.478e-05 0.0002771
50 DOUBLE STRANDED DNA BINDING 16 764 1.492e-05 0.0002771
51 CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY 4 28 2.332e-05 0.0004249
52 PROTEIN HOMODIMERIZATION ACTIVITY 15 722 3.09e-05 0.000552
53 GAMMA CATENIN BINDING 3 12 4.567e-05 0.0008004
54 SEQUENCE SPECIFIC DNA BINDING 18 1037 5.121e-05 0.000881
55 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING 3 15 9.32e-05 0.001574
56 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 5 92 0.000241 0.003999
57 PHOSPHATASE ACTIVITY 8 275 0.0002719 0.004431
58 ADENYL NUCLEOTIDE BINDING 21 1514 0.0002793 0.004474
59 RIBONUCLEOTIDE BINDING 24 1860 0.0002855 0.004496
60 REPRESSING TRANSCRIPTION FACTOR BINDING 4 57 0.0003931 0.006086
61 TRANSCRIPTION COACTIVATOR ACTIVITY 8 296 0.0004442 0.006766
62 PROTEIN HETERODIMERIZATION ACTIVITY 10 468 0.0005588 0.00824
63 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 6 168 0.0005567 0.00824
64 BHLH TRANSCRIPTION FACTOR BINDING 3 28 0.0006336 0.009197
NumGOOverlapSizeP ValueAdj. P Value
1 BETA CATENIN DESTRUCTION COMPLEX 9 14 1.566e-17 9.144e-15
2 WNT SIGNALOSOME 8 11 2.306e-16 6.735e-14
3 PHOSPHATASE COMPLEX 11 48 4.676e-15 9.102e-13
4 PROTEIN PHOSPHATASE TYPE 2A COMPLEX 8 20 1.683e-13 2.457e-11
5 ENDOCYTIC VESICLE MEMBRANE 14 152 4.402e-13 5.142e-11
6 ENDOCYTIC VESICLE 15 256 4.343e-11 4.227e-09
7 CATALYTIC COMPLEX 27 1038 9.192e-11 7.669e-09
8 TRANSCRIPTION FACTOR COMPLEX 15 298 3.647e-10 2.662e-08
9 PROTEINACEOUS EXTRACELLULAR MATRIX 16 356 4.772e-10 3.097e-08
10 NUCLEAR CHROMATIN 14 291 2.622e-09 1.531e-07
11 EXTRACELLULAR MATRIX 16 426 6.288e-09 3.338e-07
12 CHROMATIN 16 441 1.025e-08 4.986e-07
13 CHROMOSOME 22 880 1.361e-08 6.114e-07
14 LATERAL PLASMA MEMBRANE 7 50 2.005e-08 8.364e-07
15 TRANSCRIPTIONAL REPRESSOR COMPLEX 7 74 3.205e-07 1.248e-05
16 INTRACELLULAR VESICLE 24 1259 4.466e-07 1.63e-05
17 VESICLE MEMBRANE 15 512 4.848e-07 1.666e-05
18 SYNAPSE 17 754 2.962e-06 9.61e-05
19 NUCLEAR CHROMOSOME 14 523 3.435e-06 0.0001031
20 CYTOPLASMIC VESICLE PART 15 601 3.531e-06 0.0001031
21 NUCLEAR TRANSCRIPTION FACTOR COMPLEX 7 127 1.222e-05 0.0003398
22 GOLGI LUMEN 6 94 2.283e-05 0.0006061
23 RNA POLYMERASE II TRANSCRIPTION FACTOR COMPLEX 6 101 3.434e-05 0.0008719
24 CLATHRIN COATED ENDOCYTIC VESICLE 5 65 4.61e-05 0.001122
25 SCF UBIQUITIN LIGASE COMPLEX 4 34 5.137e-05 0.00119
26 CELL SURFACE 15 757 5.3e-05 0.00119
27 EXCITATORY SYNAPSE 7 197 0.0001981 0.004211
28 CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE 4 48 0.0002019 0.004211
29 PROTEIN KINASE COMPLEX 5 90 0.0002175 0.004234
30 EXTRACELLULAR SPACE 20 1376 0.0002161 0.004234
31 TRANSFERASE COMPLEX 13 703 0.0003361 0.006133
32 SYNAPSE PART 12 610 0.0003304 0.006133
33 NUCLEAR EUCHROMATIN 3 24 0.0003984 0.007051

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04310_Wnt_signaling_pathway 121 387 4.906e-217 8.683e-215
2 hsa04916_Melanogenesis 43 387 6.179e-43 5.468e-41
3 hsa04114_Oocyte_meiosis 22 387 1.502e-15 8.864e-14
4 hsa04340_Hedgehog_signaling_pathway 21 387 1.771e-14 7.837e-13
5 hsa04010_MAPK_signaling_pathway 19 387 2.06e-12 7.292e-11
6 hsa04520_Adherens_junction 18 387 2.023e-11 5.968e-10
7 hsa04720_Long.term_potentiation 16 387 1.598e-09 4.04e-08
8 hsa04510_Focal_adhesion 15 387 1.277e-08 2.826e-07
9 hsa04020_Calcium_signaling_pathway 14 387 9.471e-08 1.397e-06
10 hsa04350_TGF.beta_signaling_pathway 14 387 9.471e-08 1.397e-06
11 hsa04360_Axon_guidance 14 387 9.471e-08 1.397e-06
12 hsa04912_GnRH_signaling_pathway 14 387 9.471e-08 1.397e-06
13 hsa04110_Cell_cycle 13 387 6.487e-07 8.201e-06
14 hsa04660_T_cell_receptor_signaling_pathway 13 387 6.487e-07 8.201e-06
15 hsa04662_B_cell_receptor_signaling_pathway 12 387 4.085e-06 4.519e-05
16 hsa04722_Neurotrophin_signaling_pathway 12 387 4.085e-06 4.519e-05
17 hsa04012_ErbB_signaling_pathway 11 387 2.353e-05 0.0001983
18 hsa04062_Chemokine_signaling_pathway 11 387 2.353e-05 0.0001983
19 hsa04370_VEGF_signaling_pathway 11 387 2.353e-05 0.0001983
20 hsa04380_Osteoclast_differentiation 11 387 2.353e-05 0.0001983
21 hsa04650_Natural_killer_cell_mediated_cytotoxicity 11 387 2.353e-05 0.0001983
22 hsa04971_Gastric_acid_secretion 10 387 0.0001232 0.0009914
23 hsa04270_Vascular_smooth_muscle_contraction 9 387 0.0005824 0.004296
24 hsa04530_Tight_junction 9 387 0.0005824 0.004296
25 hsa03015_mRNA_surveillance_pathway 8 387 0.002464 0.01745
26 hsa04210_Apoptosis 7 387 0.009241 0.05842
27 hsa04670_Leukocyte_transendothelial_migration 7 387 0.009241 0.05842
28 hsa04730_Long.term_depression 7 387 0.009241 0.05842
29 hsa04330_Notch_signaling_pathway 6 387 0.03035 0.1429
30 hsa04540_Gap_junction 6 387 0.03035 0.1429
31 hsa04620_Toll.like_receptor_signaling_pathway 6 387 0.03035 0.1429
32 hsa04630_Jak.STAT_signaling_pathway 6 387 0.03035 0.1429
33 hsa04664_Fc_epsilon_RI_signaling_pathway 6 387 0.03035 0.1429
34 hsa04810_Regulation_of_actin_cytoskeleton 6 387 0.03035 0.1429
35 hsa04910_Insulin_signaling_pathway 6 387 0.03035 0.1429
36 hsa04970_Salivary_secretion 6 387 0.03035 0.1429
37 hsa04972_Pancreatic_secretion 6 387 0.03035 0.1429
38 hsa04740_Olfactory_transduction 6 388 0.03068 0.1429
39 hsa04115_p53_signaling_pathway 5 387 0.08609 0.3544
40 hsa04120_Ubiquitin_mediated_proteolysis 5 387 0.08609 0.3544
41 hsa04141_Protein_processing_in_endoplasmic_reticulum 5 387 0.08609 0.3544
42 hsa04710_Circadian_rhythm_._mammal 5 387 0.08609 0.3544
43 hsa04914_Progesterone.mediated_oocyte_maturation 5 387 0.08609 0.3544
44 hsa04070_Phosphatidylinositol_signaling_system 4 387 0.2073 0.7978
45 hsa04621_NOD.like_receptor_signaling_pathway 4 387 0.2073 0.7978
46 hsa04622_RIG.I.like_receptor_signaling_pathway 4 387 0.2073 0.7978
47 hsa00562_Inositol_phosphate_metabolism 3 387 0.416 1
48 hsa03008_Ribosome_biogenesis_in_eukaryotes 3 387 0.416 1
49 hsa04144_Endocytosis 3 387 0.416 1
50 hsa04666_Fc_gamma_R.mediated_phagocytosis 3 387 0.416 1
51 hsa04742_Taste_transduction 3 387 0.416 1
52 hsa04920_Adipocytokine_signaling_pathway 3 387 0.416 1
53 hsa04962_Vasopressin.regulated_water_reabsorption 2 387 0.6824 1
54 hsa04976_Bile_secretion 2 387 0.6824 1

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

KCNQ1OT1

hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7c-5p;hsa-miR-10a-5p;hsa-miR-125a-5p;hsa-miR-125b-5p;hsa-miR-143-3p;hsa-miR-22-3p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-373-5p;hsa-miR-375 12 CSNK2A1 Sponge network 0.459 0.00259 0.291 0.0016 0.512
2

KCNQ1OT1

hsa-let-7b-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-194-5p;hsa-miR-22-3p;hsa-miR-23b-3p;hsa-miR-26b-5p;hsa-miR-30a-3p;hsa-miR-30c-5p;hsa-miR-30e-3p;hsa-miR-448;hsa-miR-449a 12 EP300 Sponge network 0.459 0.00259 0.106 0.05719 0.504
3

KCNQ1OT1

hsa-let-7a-5p;hsa-miR-101-3p;hsa-miR-144-3p;hsa-miR-145-5p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-152-3p;hsa-miR-192-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30a-3p;hsa-miR-30c-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-373-5p 15 SMAD2 Sponge network 0.459 0.00259 0.233 0.00027 0.502
4

HCG18

hsa-miR-125b-5p;hsa-miR-137;hsa-miR-139-5p;hsa-miR-199a-3p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30c-5p;hsa-miR-373-5p;hsa-miR-448;hsa-miR-449a 10 PLCB1 Sponge network 0.22 0.00721 0.803 0 0.471
5

KTN1-AS1

hsa-let-7a-5p;hsa-miR-101-3p;hsa-miR-144-3p;hsa-miR-145-5p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-152-3p;hsa-miR-192-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-373-5p 13 SMAD2 Sponge network 0.382 0.00019 0.233 0.00027 0.453
6

FAM99A

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-135a-5p;hsa-miR-147a;hsa-miR-15b-5p;hsa-miR-17-5p;hsa-miR-182-3p;hsa-miR-183-5p;hsa-miR-19a-3p;hsa-miR-206;hsa-miR-20a-5p 11 CCND1 Sponge network -1.52 0 -0.49 0.00116 0.452
7

HCG18

hsa-let-7a-5p;hsa-miR-101-3p;hsa-miR-144-3p;hsa-miR-145-5p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-152-3p;hsa-miR-192-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30a-3p;hsa-miR-30c-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-373-5p 15 SMAD2 Sponge network 0.22 0.00721 0.233 0.00027 0.448
8

GAS5

hsa-let-7a-5p;hsa-miR-101-3p;hsa-miR-144-3p;hsa-miR-145-5p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-152-3p;hsa-miR-192-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-373-5p 13 SMAD2 Sponge network 0.239 0.00543 0.233 0.00027 0.442
9

HCG18

hsa-let-7b-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-194-5p;hsa-miR-22-3p;hsa-miR-26b-5p;hsa-miR-30a-3p;hsa-miR-30c-5p;hsa-miR-30e-3p;hsa-miR-448;hsa-miR-449a 11 EP300 Sponge network 0.22 0.00721 0.106 0.05719 0.411
10

HCG18

hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7c-5p;hsa-miR-10a-5p;hsa-miR-10b-5p;hsa-miR-125a-5p;hsa-miR-125b-5p;hsa-miR-143-3p;hsa-miR-22-3p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-373-5p;hsa-miR-375 13 CSNK2A1 Sponge network 0.22 0.00721 0.291 0.0016 0.398
11

SCARNA15

hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7c-5p;hsa-miR-10a-5p;hsa-miR-125a-5p;hsa-miR-125b-5p;hsa-miR-143-3p;hsa-miR-22-3p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-373-5p 11 CSNK2A1 Sponge network 0.373 2.0E-5 0.291 0.0016 0.392
12

MIAT

hsa-let-7a-5p;hsa-let-7d-5p;hsa-let-7f-5p;hsa-miR-105-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-139-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-24-3p;hsa-miR-26b-5p;hsa-miR-27b-3p;hsa-miR-378a-5p 13 VANGL2 Sponge network -0.218 0.08268 -0.357 0.11321 0.363
13

GAS5

hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7c-5p;hsa-miR-10a-5p;hsa-miR-10b-5p;hsa-miR-125a-5p;hsa-miR-125b-5p;hsa-miR-22-3p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-373-5p 11 CSNK2A1 Sponge network 0.239 0.00543 0.291 0.0016 0.334
14 SNHG6 hsa-let-7a-5p;hsa-miR-101-3p;hsa-miR-144-3p;hsa-miR-145-5p;hsa-miR-148a-3p;hsa-miR-152-3p;hsa-miR-192-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30a-3p 10 SMAD2 Sponge network 0.28 0.00038 0.233 0.00027 0.331
15 SNHG8 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-135a-5p;hsa-miR-15b-5p;hsa-miR-17-5p;hsa-miR-182-3p;hsa-miR-183-5p;hsa-miR-206;hsa-miR-20a-5p;hsa-miR-34c-5p 10 CCND1 Sponge network -0.205 0.01077 -0.49 0.00116 0.318
16 SNHG5 hsa-miR-148b-3p;hsa-miR-182-5p;hsa-miR-184;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-197-3p;hsa-miR-206;hsa-miR-21-5p;hsa-miR-216a-5p;hsa-miR-330-3p 10 PRICKLE2 Sponge network -0.338 1.0E-5 -0.71 2.0E-5 0.31
17 PVT1 hsa-miR-101-3p;hsa-miR-148a-3p;hsa-miR-152-3p;hsa-miR-192-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30c-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-373-5p 10 SMAD2 Sponge network 0.192 0.00873 0.233 0.00027 0.308
18 MIR4435-1HG hsa-let-7a-5p;hsa-miR-101-3p;hsa-miR-144-3p;hsa-miR-148a-3p;hsa-miR-152-3p;hsa-miR-192-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-373-5p 11 SMAD2 Sponge network 0.509 0.00035 0.233 0.00027 0.296
19

MEG3

hsa-let-7a-5p;hsa-let-7d-5p;hsa-miR-105-5p;hsa-miR-139-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-196a-5p;hsa-miR-24-3p;hsa-miR-26b-5p;hsa-miR-30a-5p;hsa-miR-378a-5p 11 VANGL2 Sponge network 0 0.99719 -0.357 0.11321 0.284
20

KTN1-AS1

hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7c-5p;hsa-miR-10a-5p;hsa-miR-125a-5p;hsa-miR-125b-5p;hsa-miR-143-3p;hsa-miR-22-3p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-373-5p 11 CSNK2A1 Sponge network 0.382 0.00019 0.291 0.0016 0.281
21

SCARNA15

hsa-let-7a-5p;hsa-miR-101-3p;hsa-miR-144-3p;hsa-miR-145-5p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-152-3p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30e-3p;hsa-miR-373-5p 11 SMAD2 Sponge network 0.373 2.0E-5 0.233 0.00027 0.28
22

SNHG3

hsa-let-7a-5p;hsa-miR-101-3p;hsa-miR-144-3p;hsa-miR-145-5p;hsa-miR-148a-3p;hsa-miR-152-3p;hsa-miR-192-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30a-3p;hsa-miR-373-5p 11 SMAD2 Sponge network 0.394 0.00858 0.233 0.00027 0.272
23

HCG18

hsa-miR-10a-5p;hsa-miR-126-5p;hsa-miR-137;hsa-miR-139-5p;hsa-miR-143-3p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-373-5p;hsa-miR-375;hsa-miR-448 10 MAP3K7 Sponge network 0.22 0.00721 0.198 0.01129 0.262
24

MEG3

hsa-miR-105-5p;hsa-miR-148b-3p;hsa-miR-152-3p;hsa-miR-182-5p;hsa-miR-184;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-197-3p;hsa-miR-206;hsa-miR-216a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-330-3p;hsa-miR-346 15 PRICKLE2 Sponge network 0 0.99719 -0.71 2.0E-5 0.255
25

SNHG3

hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7c-5p;hsa-miR-10a-5p;hsa-miR-125a-5p;hsa-miR-125b-5p;hsa-miR-22-3p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-373-5p 10 CSNK2A1 Sponge network 0.394 0.00858 0.291 0.0016 0.251

Quest ID: 9d0f1b4f7a6f7afc869384b9ca1a676f